subject: CHEBI:151315

subject_name: Heparin

object_name: myocardial infarction


subject: CHEBI:151315

object_name: Myocardial Infarction, CTCAE

tested_intervention: unsure


subject: CHEBI:151315

object_name: Myocardial Infarction by ECG Finding


subject: CHEBI:151315

object_name: angina unstable


subject: GTOPDB:6803

subject_name: dalteparin


subject: GTOPDB:6803


subject: GTOPDB:6803


subject: GTOPDB:6803


subject: UNII:PUE0TO3XDR

subject_name: Dalteparin


subject: UNII:PUE0TO3XDR


subject: UNII:PUE0TO3XDR


subject: UNII:PUE0TO3XDR


subject: CHEBI:3077

subject_name: Betamethasone

object_name: de Quervain disease

tested_intervention: yes


subject: CHEBI:94534

subject_name: olanzapine

object_name: Advanced cancer


subject: CHEBI:94534

object_name: progression free survival


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: hepatitis C


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UMLS:C3537249

subject_name: D Vitamin


subject: UMLS:C4724850

subject_name: Lactobacillus reuteri Probiotic Tablet

object_name: disease transmission


subject: CHEBI:61049

subject_name: Tacrolimus

object_name: lupus nephritis


subject: UMLS:C4721945

subject_name: perflutren, human albumin microspheres

object_name: liver neoplasm


subject: UMLS:C4721945

object_name: liver cancer


subject: UMLS:C4721945

object_name: Adult Liver Carcinoma


subject: UMLS:C4721945

object_name: liver carcinoma


subject: CHEBI:3770

subject_name: co-trimoxazole

object_name: pneumocystosis


subject: CHEBI:3770

object_name: Pneumocystis infectious disease


subject: CHEBI:3770

object_name: Infection by Pneumocystis jirovecii (disorder)


subject: CHEBI:3770

object_name: Pneumocystosis with AIDS (acquired immunodeficiency syndrome)


subject: CHEBI:3770

object_name: pneumocystosis; pneumonia (etiology)


subject: CHEBI:3770

object_name: HIV disease resulting in Pneumocystis carinii pneumonia


subject: UMLS:C0041044


subject: UMLS:C0041044


subject: UMLS:C0041044


subject: UMLS:C0041044


subject: UMLS:C0041044


subject: UMLS:C0041044


subject: UNII:5QS67N4551

subject_name: Conestat alfa


subject: UMLS:C2366367

subject_name: Cinryze


subject: UMLS:C3534680

subject_name: Injection, icatibant, 1 mg


subject: UMLS:C5203333

subject_name: Icatibant Injection


subject: CHEBI:135966

subject_name: Carisbamate

object_name: partial motor epilepsy


subject: CHEBI:135966

object_name: Epilepsy, Simple Partial


subject: CHEBI:135966

object_name: complex partial epilepsy


subject: CHEBI:10033

subject_name: Warfarin

object_name: atrial fibrillation


subject: CHEBI:10033

object_name: Atrial Fibrillation by ECG Finding


subject: CHEBI:10033

object_name: Atrial Fibrillation, CTCAE


subject: CHEBI:10033

object_name: stroke disorder


subject: CHEBI:10033

object_name: cerebrovascular disorder


subject: CHEBI:10033

object_name: Stroke (heart beat)


subject: CHEBI:10033

object_name: Stroke, CTCAE


subject: CHEBI:3757

subject_name: Clonidine

object_name: Mental deterioration


subject: CHEBI:3757

object_name: Cognitive impairment


subject: CHEBI:3757

object_name: delirium


subject: CHEBI:3757

object_name: Delirium, CTCAE


subject: CHEBI:3757

object_name: Frailty


subject: CHEBI:4466

subject_name: Dexmedetomidine


subject: CHEBI:4466


subject: CHEBI:4466


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UNII:7N8K34P2XH


subject: UNII:7N8K34P2XH


subject: CHEBI:45783

subject_name: Imatinib

object_name: uterine cancer


subject: CHEBI:45783

object_name: tumor of uterus


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:45863


subject: UMLS:C4725757

subject_name: Lutetium Lu-177 PSMA-R2

object_name: prostate cancer


subject: UMLS:C4725757

object_name: prostate neoplasm


subject: CHEBI:25523

subject_name: NADP

object_name: colorectal neoplasm


subject: CHEBI:18009

subject_name: NADP(+)


subject: CHEBI:3639

subject_name: chlorothalonil


subject: PR:000016053

subject_name: tapasin


subject: UMLS:C0338204

subject_name: Herceptin

object_name: salivary duct carcinoma


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: glaucoma


subject: CHEBI:41879

object_name: Glaucoma, CTCAE


subject: CHEBI:17650

subject_name: Hydrocortisone

object_name: adrenocortical insufficiency


subject: CHEBI:17650

object_name: Adrenal Insufficiency, CTCAE


subject: GTOPDB:5070

subject_name: LIGHT

object_name: atopic eczema


subject: GTOPDB:5070

object_name: dermatitis


subject: GTOPDB:5070

object_name: Eczema, CTCAE


subject: CHEBI:30212

subject_name: photon


subject: CHEBI:30212


subject: CHEBI:30212


subject: PR:000002222

subject_name: tumor necrosis factor ligand superfamily member 14


subject: PR:000002222


subject: PR:000002222


subject: UMLS:C0982273

subject_name: MENINGOCOCCAL POLYSACCHARIDE

object_name: meningococcal meningitis


subject: UMLS:C0982273

object_name: meningococcal infection


subject: UMLS:C0982273

object_name: meningitis


subject: UMLS:C0982273

object_name: Meningitis, CTCAE


subject: UMLS:C4524378

subject_name: Fluorine F 18 Integrin Alpha v Beta 6-targeted Peptide


subject: MESH:C000727548

object_name: melanoma


subject: UNII:6JLQ8K35KK

subject_name: Gavorestat

object_name: classic galactosemia


subject: UMLS:C5813439


subject: CHEBI:51254

subject_name: AMOXICILLIN

object_name: Peri-Implantitis


subject: PUBCHEM.COMPOUND:2171


subject: CHEBI:2676

subject_name: Amoxicillin


subject: UNII:L500PR95QA

subject_name: METRONIDAZOLE PHOSPHATE


subject: CHEBI:6909

subject_name: Metronidazole


subject: UMLS:C5226991

object_name: Congenital IGHD


subject: UMLS:C5226991

object_name: Reduced circulating growth hormone concentration


subject: CHEMBL.COMPOUND:CHEMBL3833369

subject_name: FISH OIL

object_name: hyperlipidemia


subject: CHEMBL.COMPOUND:CHEMBL3833369

object_name: hyperlipoproteinemia


subject: CHEMBL.COMPOUND:CHEMBL3833369

object_name: Hyperlipidemia, CTCAE


subject: CHEMBL.COMPOUND:CHEMBL3833369

object_name: Serum lipids high (finding)


subject: CHEBI:31347

subject_name: camostat mesylate

object_name: Cardiac complication


subject: CHEBI:31347

object_name: blood coagulation disease


subject: UMLS:C0108225

subject_name: Camostat mesylate


subject: UMLS:C0108225


subject: CHEBI:85993

subject_name: Palbociclib

object_name: female breast carcinoma


subject: CHEBI:2704

subject_name: Anastrozole


subject: CHEBI:33569

subject_name: noradrenaline

object_name: septic shock


subject: CHEBI:33569

object_name: acute kidney failure


subject: CHEBI:33569

object_name: Acute Kidney Injury, CTCAE


subject: CHEBI:18357

subject_name: Norepinephrine


subject: CHEBI:18357


subject: CHEBI:18357


subject: PUBCHEM.COMPOUND:53477739

subject_name: Vasopressin


subject: PUBCHEM.COMPOUND:53477739


subject: PUBCHEM.COMPOUND:53477739


subject: PUBCHEM.COMPOUND:11979316


subject: PUBCHEM.COMPOUND:11979316


subject: PUBCHEM.COMPOUND:11979316


subject: UMLS:C5966161

subject_name: Vasopressin (anatomical)


subject: UMLS:C5966161


subject: UMLS:C5966161


subject: PUBCHEM.COMPOUND:3367

object_name: Severe Aplastic Anemia


subject: PUBCHEM.COMPOUND:3367

object_name: severe aplastic anemia


subject: PUBCHEM.COMPOUND:3367

object_name: chronic leukemia


subject: PUBCHEM.COMPOUND:3367

object_name: acute leukemia


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:124959

subject_name: Tilarginine

object_name: obstructive sleep apnea syndrome


subject: UMLS:C0069477


subject: CHEBI:58097

object_name: Neonatal disorder


subject: CHEBI:17303

subject_name: Morphine


subject: GTOPDB:8002

subject_name: bavituximab

object_name: Childhood Breast Carcinoma


subject: GTOPDB:8002

object_name: breast carcinoma


subject: GTOPDB:8002

object_name: breast cancer


subject: UNII:Q16CT95N25


subject: UNII:Q16CT95N25


subject: UNII:Q16CT95N25


subject: UMLS:C1707382


subject: UMLS:C1707382


subject: UMLS:C1707382


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED

object_name: low grade glioma


subject: CHEBI:72564

subject_name: Temozolomide


subject: UMLS:C4287710

subject_name: Fluorescent Antibody SGM-101

object_name: colorectal neoplasm


subject: CHEBI:63791

subject_name: Lenalidomide

object_name: sinus histiocytosis with massive lymphadenopathy


subject: CHEBI:41879

subject_name: Dexamethasone


subject: DRUGBANK:DB17293

subject_name: Hiltonol

object_name: Malignant neoplasm of colon stage IV


subject: DRUGBANK:DB17293

object_name: Childhood Solid Neoplasm


subject: DRUGBANK:DB17293

object_name: Adult Solid Neoplasm


subject: DRUGBANK:DB17293

object_name: Solid Neoplasm


subject: UNII:7KYP9TKT70

subject_name: poly ICLC


subject: UNII:7KYP9TKT70


subject: UNII:7KYP9TKT70


subject: UNII:7KYP9TKT70


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: CHEBI:31355

subject_name: Carboplatin

object_name: endometrial cancer


subject: CHEBI:31355

object_name: uterine corpus cancer


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:45863


subject: CHEBI:51254

subject_name: AMOXICILLIN

object_name: pneumonia


subject: CHEBI:51254

object_name: COVID-19-Associated Pneumonia


subject: CHEBI:51254

object_name: Acute respiratory infections


subject: PUBCHEM.COMPOUND:2171


subject: PUBCHEM.COMPOUND:2171


subject: PUBCHEM.COMPOUND:2171


subject: CHEBI:2676

subject_name: Amoxicillin


subject: CHEBI:2676


subject: CHEBI:2676


subject: PUBCHEM.COMPOUND:66964417

subject_name: LACTULOSE

object_name: hepatic encephalopathy


subject: PUBCHEM.COMPOUND:66964417

object_name: liver cirrhosis


subject: PUBCHEM.COMPOUND:66964417

object_name: portal hypertension


subject: PUBCHEM.COMPOUND:66964417

object_name: Portal Hypertension, CTCAE


subject: UNII:9U7D5QH5AE


subject: UNII:9U7D5QH5AE


subject: UNII:9U7D5QH5AE


subject: UNII:9U7D5QH5AE


subject: PUBCHEM.COMPOUND:46783403

subject_name: Rifaximin


subject: PUBCHEM.COMPOUND:46783403


subject: PUBCHEM.COMPOUND:46783403


subject: UNII:3E93IV1U45

subject_name: Sumanirole

object_name: Parkinson disease


subject: CHEBI:9907

subject_name: ursodiol

object_name: Gallstone pancreatitis


subject: UMLS:C2703096

object_name: Cervical high grade squamous intraepithelial lesion


subject: UMLS:C2703096

object_name: High Grade Squamous Intraepithelial Neoplasia


subject: UMLS:C2703096

object_name: High-Grade Squamous Intraepithelial Lesions


subject: UMLS:C2703096

object_name: cervical intraepithelial neoplasia


subject: UMLS:C2703096

object_name: dysplasia of cervix


subject: CHEBI:135515

subject_name: Bendamustine

object_name: Adult Classical Hodgkin Lymphoma


subject: CHEBI:64816


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:8382

subject_name: Prednisone


subject: CHEBI:27375

subject_name: Vinblastine


subject: CHEBI:4445

subject_name: Desflurane

object_name: liver carcinoma


subject: CHEBI:4445

object_name: gallbladder neoplasm


subject: CHEBI:4445

object_name: cholangiocarcinoma


subject: CHEBI:4445

object_name: liver neoplasm


subject: CHEBI:9130

subject_name: Sevoflurane


subject: CHEBI:9130


subject: CHEBI:9130


subject: CHEBI:9130


subject: CHEBI:94366

subject_name: itraconazole

object_name: non-small cell lung carcinoma


subject: PUBCHEM.COMPOUND:135512673

subject_name: Rifampicin


subject: HMDB:HMDB0015179

subject_name: Rifampin


subject: CHEBI:192614

subject_name: Homosildenafil

object_name: systemic sclerosis


subject: UNII:L6WO34R9YG

subject_name: N-Desmethyl sildenafil (UK-103,320)


subject: PUBCHEM.COMPOUND:131769997

subject_name: Hydromorphone 3-beta-O-glucuronide


subject: CHEBI:183660

subject_name: Acetildenafil


subject: UNII:80X7B1F6NW

subject_name: LODENAFIL


subject: CHEBI:9139

subject_name: Sildenafil


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: prostate carcinoma


subject: CHEBI:41879

object_name: prostate cancer


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:60789

subject_name: bupivacaine hydrochloride hydrate

object_name: Post-Operative Pain


subject: UNII:16VY3TM7ZO

subject_name: Antineoplaston A10

object_name: Childhood Brain Neoplasm


subject: UMLS:C4721487

subject_name: ATENGENAL


subject: UMLS:C4721495

subject_name: Astugenal


subject: UMLS:C5848866

subject_name: Immunotherapy [APC]

object_name: metastatic malignant neoplasm in the brain


subject: UMLS:C5848866

object_name: Metastatic non-small cell lung cancer


subject: UNII:8M7YSN2KII

subject_name: nortramadol

object_name: esophageal squamous cell carcinoma


subject: CHEBI:51112


subject: CHEBI:34827


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: UniProtKB:P15379-4

subject_name: CD44 antigen isoform 4 (mouse)


subject: CHEBI:39465

subject_name: timolol

object_name: ocular hypertension


subject: CHEBI:39465

object_name: Ocular hypertension


subject: CHEBI:39465

object_name: open-angle glaucoma


subject: CHEMBL.COMPOUND:CHEMBL4650378

subject_name: AZOXIMER BROMIDE

object_name: Coronavinae infectious disease


subject: UNII:N19A0T0E5J

subject_name: Parathyroid hormone

object_name: osteoporosis


subject: UNII:N19A0T0E5J

object_name: Encounter due to family history of osteoporosis


subject: UNII:N19A0T0E5J

object_name: Osteoporosis, CTCAE 5.0


subject: UNII:N19A0T0E5J

object_name: Osteoporosis, CTCAE 3.0


subject: GTOPDB:1786

subject_name: PTH


subject: GTOPDB:1786


subject: GTOPDB:1786


subject: GTOPDB:1786


subject: CHEBI:229236

subject_name: Fezolinetant


subject: CHEBI:6456

subject_name: Lidocaine

object_name: Non-viable pregnancy


subject: CHEBI:17154

subject_name: Nicotinamide

object_name: Liver Fibrosis


subject: CHEBI:17154

object_name: Fatty Liver


subject: CHEBI:17154

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:17154

object_name: obesity


subject: CHEBI:17154

object_name: Obesity, CTCAE


subject: CHEBI:17154

object_name: metabolic dysfunction-associated steatotic liver disease


subject: CHEBI:64312

subject_name: Memantine

object_name: traumatic encephalopathy


subject: CHEBI:64312

object_name: traumatic brain injury


subject: CHEBI:6715

subject_name: medroxyprogesterone

object_name: Abnormal uterine bleeding


subject: CHEBI:6715

object_name: Metrorrhagia


subject: CHEBI:119486

subject_name: Efavirenz

object_name: Drug Interactions


subject: UNII:43K1W2T1M6

subject_name: Interferon alfa-2b

object_name: superficial urinary bladder carcinoma


subject: UMLS:C1610033

subject_name: Interferon Alpha, Human


subject: PR:000024938

subject_name: interferon alpha


subject: UMLS:C2825023

subject_name: Interferon alpha [EPC]


subject: UMLS:C5421030

object_name: hemophilia A


subject: UMLS:C1268855

subject_name: Gonadotropin releasing hormone antagonist

object_name: prostate carcinoma


subject: UMLS:C1268855

object_name: prostate cancer


subject: UMLS:C3537040

subject_name: Gonadotropin Releasing Hormone Antagonist [EPC]


subject: UMLS:C3537040


subject: UMLS:C4329338

subject_name: Anti-PD-L1 Monoclonal Antibody FAZ053

object_name: triple-negative breast carcinoma


subject: UMLS:C4329338

object_name: Triple-Negative Breast Cancer Finding


subject: CHEBI:135353

subject_name: Tinoridine

object_name: Inflammation


subject: CHEBI:59224

subject_name: Cetrorelix

object_name: endometriosis


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil

object_name: stage IVA rectal cancer


subject: PUBCHEM.COMPOUND:14907381

object_name: Stage IVA Rectal Cancer AJCC v7


subject: PUBCHEM.COMPOUND:14907381

object_name: Stage IVA Rectal Cancer AJCC v8


subject: PUBCHEM.COMPOUND:14907381

object_name: Stage IVB Rectal Cancer AJCC v7


subject: PUBCHEM.COMPOUND:14907381

object_name: Stage IVB Rectal Cancer AJCC v8


subject: PUBCHEM.COMPOUND:14907381

object_name: stage IVB rectal cancer


subject: PUBCHEM.COMPOUND:14907381

object_name: Recurrent Rectal Cancer


subject: PUBCHEM.COMPOUND:14907381

object_name: stage IVB colon cancer


subject: PUBCHEM.COMPOUND:14907381

object_name: Stage IVB Colon Cancer AJCC v7


subject: PUBCHEM.COMPOUND:14907381

object_name: Stage IVB Colon Cancer AJCC v8


subject: PUBCHEM.COMPOUND:14907381

object_name: stage IVA colon cancer


subject: PUBCHEM.COMPOUND:14907381

object_name: Stage IVA Colon Cancer AJCC v7


subject: PUBCHEM.COMPOUND:14907381

object_name: Stage IVA Colon Cancer AJCC v8


subject: PUBCHEM.COMPOUND:14907381

object_name: Colon cancer recurrent


subject: PUBCHEM.COMPOUND:14907381

object_name: colon signet ring cell adenocarcinoma


subject: PUBCHEM.COMPOUND:14907381

object_name: rectal signet ring cell adenocarcinoma


subject: PUBCHEM.COMPOUND:14907381

object_name: colon mucinous adenocarcinoma


subject: PUBCHEM.COMPOUND:14907381

object_name: rectum mucinous adenocarcinoma


subject: CHEBI:46345

subject_name: Fluorouracil

object_name: stage IVA rectal cancer


subject: CHEBI:46345

object_name: Stage IVA Rectal Cancer AJCC v7


subject: CHEBI:46345

object_name: Stage IVA Rectal Cancer AJCC v8


subject: CHEBI:46345

object_name: Stage IVB Rectal Cancer AJCC v7


subject: CHEBI:46345

object_name: Stage IVB Rectal Cancer AJCC v8


subject: CHEBI:46345

object_name: stage IVB rectal cancer


subject: CHEBI:46345

object_name: Recurrent Rectal Cancer


subject: CHEBI:46345

object_name: stage IVB colon cancer


subject: CHEBI:46345

object_name: Stage IVB Colon Cancer AJCC v7


subject: CHEBI:46345

object_name: Stage IVB Colon Cancer AJCC v8


subject: CHEBI:46345

object_name: stage IVA colon cancer


subject: CHEBI:46345

object_name: Stage IVA Colon Cancer AJCC v7


subject: CHEBI:46345

object_name: Stage IVA Colon Cancer AJCC v8


subject: CHEBI:46345

object_name: Colon cancer recurrent


subject: CHEBI:46345

object_name: colon signet ring cell adenocarcinoma


subject: CHEBI:46345

object_name: rectal signet ring cell adenocarcinoma


subject: CHEBI:46345

object_name: colon mucinous adenocarcinoma


subject: CHEBI:46345

object_name: rectum mucinous adenocarcinoma


subject: CHEBI:15640

subject_name: Leucovorin

object_name: stage IVA rectal cancer


subject: CHEBI:15640

object_name: Stage IVA Rectal Cancer AJCC v7


subject: CHEBI:15640

object_name: Stage IVA Rectal Cancer AJCC v8


subject: CHEBI:15640

object_name: Stage IVB Rectal Cancer AJCC v7


subject: CHEBI:15640

object_name: Stage IVB Rectal Cancer AJCC v8


subject: CHEBI:15640

object_name: stage IVB rectal cancer


subject: CHEBI:15640

object_name: Recurrent Rectal Cancer


subject: CHEBI:15640

object_name: stage IVB colon cancer


subject: CHEBI:15640

object_name: Stage IVB Colon Cancer AJCC v7


subject: CHEBI:15640

object_name: Stage IVB Colon Cancer AJCC v8


subject: CHEBI:15640

object_name: stage IVA colon cancer


subject: CHEBI:15640

object_name: Stage IVA Colon Cancer AJCC v7


subject: CHEBI:15640

object_name: Stage IVA Colon Cancer AJCC v8


subject: CHEBI:15640

object_name: Colon cancer recurrent


subject: CHEBI:15640

object_name: colon signet ring cell adenocarcinoma


subject: CHEBI:15640

object_name: rectal signet ring cell adenocarcinoma


subject: CHEBI:15640

object_name: colon mucinous adenocarcinoma


subject: CHEBI:15640

object_name: rectum mucinous adenocarcinoma


subject: UNII:15C2VL427D

subject_name: Aflibercept

object_name: stage IVA rectal cancer


subject: UNII:15C2VL427D

object_name: Stage IVA Rectal Cancer AJCC v7


subject: UNII:15C2VL427D

object_name: Stage IVA Rectal Cancer AJCC v8


subject: UNII:15C2VL427D

object_name: Stage IVB Rectal Cancer AJCC v7


subject: UNII:15C2VL427D

object_name: Stage IVB Rectal Cancer AJCC v8


subject: UNII:15C2VL427D

object_name: stage IVB rectal cancer


subject: UNII:15C2VL427D

object_name: Recurrent Rectal Cancer


subject: UNII:15C2VL427D

object_name: stage IVB colon cancer


subject: UNII:15C2VL427D

object_name: Stage IVB Colon Cancer AJCC v7


subject: UNII:15C2VL427D

object_name: Stage IVB Colon Cancer AJCC v8


subject: UNII:15C2VL427D

object_name: stage IVA colon cancer


subject: UNII:15C2VL427D

object_name: Stage IVA Colon Cancer AJCC v7


subject: UNII:15C2VL427D

object_name: Stage IVA Colon Cancer AJCC v8


subject: UNII:15C2VL427D

object_name: Colon cancer recurrent


subject: UNII:15C2VL427D

object_name: colon signet ring cell adenocarcinoma


subject: UNII:15C2VL427D

object_name: rectal signet ring cell adenocarcinoma


subject: UNII:15C2VL427D

object_name: colon mucinous adenocarcinoma


subject: UNII:15C2VL427D

object_name: rectum mucinous adenocarcinoma


subject: UMLS:C0699617

subject_name: Norditropin

object_name: Turner syndrome


subject: GTOPDB:4942

subject_name: GM-CSF

object_name: leukemia


subject: GTOPDB:4942

object_name: childhood leukemia


subject: UMLS:C0376563

subject_name: Recombinant Granulocyte-Macrophage Colony-Stimulating Factors


subject: UMLS:C0376563


subject: UNII:43K1W2T1M6


subject: UNII:43K1W2T1M6


subject: UMLS:C0021735

subject_name: Viraferon


subject: UMLS:C0021735


subject: CHEBI:151315

subject_name: Heparin


subject: CHEBI:151315

object_name: Thromboembolism


subject: GTOPDB:6803

subject_name: dalteparin


subject: GTOPDB:6803


subject: UNII:PUE0TO3XDR

subject_name: Dalteparin


subject: CHEBI:82339

subject_name: Merphalan

object_name: sickle cell disease


subject: CHEBI:28876

subject_name: Melphalan


subject: CHEBI:63791

subject_name: Lenalidomide

object_name: Plasma cell myeloma recurrent


subject: UNII:S7RL72610R

subject_name: gossypol acetic acid


subject: PUBCHEM.COMPOUND:35450

subject_name: GOSSYPOL ACETIC ACID


subject: PUBCHEM.COMPOUND:22327742

subject_name: Gosspyl acetate


subject: CHEBI:72296

subject_name: Apixaban

object_name: 3-lead electrocardiogram rhythm strip: sinus rhythm


subject: CHEBI:72296

object_name: Sinus Rhythm


subject: CHEBI:72296

object_name: heart failure


subject: CHEBI:72296

object_name: Heart Failure, CTCAE


subject: CHEBI:72296

object_name: cerebrovascular disorder


subject: CHEBI:231679

subject_name: ipilimumab

object_name: liver cancer


subject: CHEBI:231679

object_name: Surgical procedure finding


subject: CHEBI:231679

object_name: liver carcinoma


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: UNII:DPT0O3T46P


subject: UNII:28X28X9OKV

subject_name: Durvalumab


subject: UNII:28X28X9OKV


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: PUBCHEM.COMPOUND:3685


subject: PUBCHEM.COMPOUND:3685


subject: PUBCHEM.COMPOUND:3685


subject: CHEBI:42068

subject_name: Idarubicin


subject: CHEBI:42068


subject: CHEBI:42068


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab


subject: UNII:2S9ZZM9Q9V


subject: UNII:6DX9Y74D3E

object_name: Buerger Disease


subject: UMLS:C5853350


subject: CHEBI:8802

subject_name: Remifentanil

object_name: Dysesthesia


subject: UNII:2P471X1Z11

subject_name: Omalizumab

object_name: chronic idiopathic urticaria


subject: UMLS:C0910794


subject: UMLS:C2830125

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:145371

subject_name: Binimetinib


subject: MESH:D017077

subject_name: Culture Media, Conditioned

object_name: keloid


subject: PUBCHEM.COMPOUND:633097

subject_name: Kenalog


subject: CHEBI:9667

subject_name: Triamcinolone


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: chronic otitis media


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UMLS:C3819106

subject_name: Pedia-Lax Probiotic

object_name: perinatal necrotizing enterocolitis


subject: UMLS:C3819106

object_name: necrotizing enterocolitis


subject: UMLS:C3819106

object_name: Necrotizing Enterocolitis, AE


subject: UMLS:C3819106

object_name: Growth delay


subject: UMLS:C3819106

object_name: Failure to Thrive


subject: UMLS:C3819106

object_name: difficult; feeding, newborn


subject: UMLS:C3819106

object_name: Sepsis


subject: UMLS:C3819106

object_name: Sepsis, CTCAE


subject: CHEBI:31797

subject_name: Gadolinium DTPA

object_name: stricture


subject: CHEBI:180856

subject_name: Hovenoside G


subject: UMLS:C0721529

subject_name: Magnevist


subject: CHEBI:46295

subject_name: Vardenafil

object_name: impotence


subject: CHEBI:46295

object_name: sexual disorder


subject: CHEBI:46295

object_name: physiological sexual disorder


subject: UMLS:C4287698

subject_name: Cobolimab

object_name: Adult Liver Carcinoma


subject: UMLS:C4287698

object_name: advanced adult primary liver cancer


subject: UMLS:C4287698

object_name: Localized Non-Resectable Adult Liver Carcinoma


subject: UMLS:C4287697


subject: UMLS:C4287697


subject: UMLS:C4287697


subject: UMLS:C2933824

object_name: hepatitis C


subject: UMLS:C2933824

object_name: chronic hepatitis C virus infection


subject: CHEBI:82977

subject_name: Daclatasvir


subject: CHEBI:82977


subject: PUBCHEM.COMPOUND:9904258

object_name: epilepsy


subject: UMLS:C0962483


subject: CHEBI:63631

subject_name: Topiramate


subject: CHEBI:5441

subject_name: Glyburide

object_name: type 2 diabetes mellitus


subject: CHEBI:231353

subject_name: Orteronel

object_name: prostate carcinoma


subject: CHEBI:231353

object_name: prostate cancer


subject: PUBCHEM.COMPOUND:657301

subject_name: TERBUTALINE SULFATE

object_name: Poroid Hidradenoma


subject: PUBCHEM.COMPOUND:657301

object_name: progestogen hypersensitivity


subject: PUBCHEM.COMPOUND:657301

object_name: Philadelphia Chromosome


subject: PUBCHEM.COMPOUND:657301

object_name: Past history of


subject: PUBCHEM.COMPOUND:657301

object_name: Infusion pump Alert priority PH


subject: PUBCHEM.COMPOUND:657301

object_name: Finding of pH


subject: CHEBI:9449

subject_name: Terbutaline


subject: CHEBI:9449


subject: CHEBI:9449


subject: CHEBI:9449


subject: CHEBI:9449


subject: CHEBI:9449


subject: CHEBI:94463

object_name: Lassa fever


subject: CHEBI:63580

subject_name: Ribavirin


subject: CHEBI:6801

subject_name: Metformin

object_name: female infertility


subject: PUBCHEM.COMPOUND:3035406

subject_name: Caspofungin

object_name: Mycoses


subject: UNII:7DR7JMB8BH

object_name: metastatic malignant neoplasm in the brain


subject: UNII:7DR7JMB8BH

object_name: non-small cell lung carcinoma


subject: UNII:SMA5ZS5B22

subject_name: Ensartinib


subject: UNII:SMA5ZS5B22


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Childhood Breast Carcinoma


subject: CHEBI:4026

object_name: breast carcinoma


subject: CHEBI:4026

object_name: breast cancer


subject: CHEBI:231601

subject_name: trastuzumab


subject: CHEBI:231601


subject: CHEBI:231601


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UMLS:C3661275

object_name: thyroid tumor


subject: UMLS:C3661275

object_name: thyroid gland carcinoma


subject: UMLS:C3661275

object_name: thyroid cancer


subject: UMLS:C3661275

object_name: thyroid gland undifferentiated (anaplastic) carcinoma


subject: UMLS:C3661275

object_name: differentiated thyroid carcinoma


subject: CHEBI:91450

subject_name: Sapanisertib


subject: CHEBI:91450


subject: CHEBI:91450


subject: CHEBI:91450


subject: CHEBI:91450


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED

object_name: Disseminated Malignant Neoplasm


subject: UMLS:C0919079

object_name: Embolism, Tumor


subject: UMLS:C0919079

object_name: Neoplasm Metastasis


subject: CHEBI:72564

subject_name: Temozolomide


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:229212

subject_name: Pirtobrutinib

object_name: diffuse large B-cell lymphoma


subject: CHEBI:229212

object_name: mantle cell lymphoma


subject: CHEBI:229212

object_name: marginal zone lymphoma


subject: CHEBI:229212

object_name: MALT lymphoma


subject: CHEBI:229212

object_name: non-Hodgkin lymphoma


subject: CHEBI:229212

object_name: follicular lymphoma


subject: CHEBI:229212

object_name: Burkitt lymphoma


subject: CHEBI:229212

object_name: Childhood Burkitt Lymphoma


subject: CHEBI:229212

object_name: Adult Burkitt Lymphoma


subject: UMLS:C5667057

subject_name: Cafelkibart

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:135954

subject_name: Bilastine

object_name: urticaria


subject: CHEBI:135954

object_name: reported urticaria (physical finding)


subject: CHEBI:135954

object_name: Urticaria, CTCAE


subject: CHEBI:3181

subject_name: Bromocriptine

object_name: peripartum cardiomyopathy


subject: CHEBI:3181

object_name: Dilated peripartum cardiomyopathy


subject: CHEBI:36796

subject_name: duloxetine

object_name: post-traumatic stress disorder


subject: CHEBI:49900

subject_name: Arsenous acid

object_name: acute promyelocytic leukemia


subject: PUBCHEM.COMPOUND:518740

subject_name: Arsenic trioxide


subject: CHEBI:30621

subject_name: diarsenic trioxide


subject: UNII:S7V92P67HO


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide


subject: CHEBI:28680

subject_name: Cytarabine


subject: CHEBI:41879

subject_name: Dexamethasone


subject: PUBCHEM.COMPOUND:3685


subject: CHEBI:42068

subject_name: Idarubicin


subject: PUBCHEM.COMPOUND:5458171

subject_name: MITOXANTRONE HYDROCHLORIDE


subject: CHEBI:50729

subject_name: Mitoxantrone


subject: CHEBI:15367

subject_name: Tretinoin


subject: CHEBI:50648

subject_name: Alitretinoin


subject: CHEBI:231614

subject_name: Nivolumab

object_name: nonpapillary renal cell carcinoma


subject: CHEBI:231614

object_name: clear cell renal carcinoma


subject: CHEBI:231614

object_name: renal cell adenocarcinoma


subject: CHEBI:231614

object_name: renal cell carcinoma


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UNII:54534MX6Z9

subject_name: Teclistamab

object_name: Plasma cell myeloma refractory


subject: UNII:54534MX6Z9

object_name: Plasma cell myeloma recurrent


subject: UMLS:C4527013


subject: UMLS:C4527013


subject: UNII:S7H48S6K7H

subject_name: Troriluzole

object_name: glioblastoma


subject: UNII:S7H48S6K7H

object_name: Childhood Glioblastoma


subject: UNII:S7H48S6K7H

object_name: adult glioblastoma


subject: UNII:S7H48S6K7H

object_name: Recurrent Childhood Glioblastoma


subject: UNII:S7H48S6K7H

object_name: Recurrent Glioblastoma


subject: UNII:S7H48S6K7H

object_name: brain neoplasm


subject: CHEBI:95021

subject_name: pemetrexed

object_name: neoplasm


subject: CHEBI:63724


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: UMLS:C4086713

subject_name: Substance with programmed cell death protein 1 inhibitor mechanism of action (substance)

object_name: rectal carcinoma


subject: UMLS:C4086713

object_name: rectal cancer


subject: UMLS:C4086713

object_name: Childhood Rectal Carcinoma


subject: UMLS:C4086713

object_name: colon carcinoma


subject: UMLS:C4086713

object_name: colorectal cancer


subject: UMLS:C4086713

object_name: colon cancer


subject: PUBCHEM.COMPOUND:3080587

subject_name: Megestrol

object_name: Stage I Endometrial Carcinoma


subject: CHEBI:38545

subject_name: Rosuvastatin


subject: CHEBI:36796

subject_name: duloxetine

object_name: osteoarthritis, knee


subject: PUBCHEM.COMPOUND:4715169

subject_name: 3-(Aminomethyl)-5-methylhexanoic acid


subject: CHEBI:64356

subject_name: Pregabalin


subject: CHEBI:7465

subject_name: Naltrexone

object_name: nicotine dependence


subject: CHEBI:6541

subject_name: Losartan

object_name: post-traumatic stress disorder


subject: CHEBI:6541

object_name: BH4-deficient hyperphenylalaninemia A


subject: CHEBI:205919

subject_name: Clobetasol

object_name: Chronic small plaque psoriasis


subject: PUBCHEM.COMPOUND:6435378

subject_name: iloprost

object_name: asthma


subject: UMLS:C3658854

object_name: atopic eczema


subject: UMLS:C4547381

object_name: Invasive pulmonary aspergillosis


subject: MESH:C508870

subject_name: gemcitabine-oxaliplatin regimen

object_name: intrahepatic cholangiocarcinoma


subject: CHEBI:84500

subject_name: varenicline

object_name: drug dependence


subject: PUBCHEM.COMPOUND:56841942

subject_name: Narlaprevir

object_name: hepatitis C


subject: UMLS:C2974454

subject_name: narlaprevir


subject: CHEBI:45409

subject_name: Ritonavir


subject: UMLS:C5706298

subject_name: Ketone-IQ

object_name: obstructive sleep apnea syndrome


subject: CHEBI:71940

subject_name: Tadalafil

object_name: Neck Carcinoma


subject: CHEBI:71940

object_name: head and neck neoplasm


subject: CHEBI:71940

object_name: head and neck cancer


subject: UNII:FYS6T7F842

subject_name: Adalimumab

object_name: psoriasis


subject: UNII:FYS6T7F842

object_name: psoriatic arthritis


subject: UNII:FYS6T7F842

object_name: ulcerative colitis


subject: UNII:FYS6T7F842

object_name: inflammatory bowel disease 1


subject: CHEBI:5118

subject_name: Fluoxetine

object_name: Non-Erosive Reflux Disease


subject: CHEBI:7772

subject_name: omeprazole


subject: CHEBI:77260

subject_name: Omeprazole


subject: CHEBI:27732

subject_name: Caffeine

object_name: post operative nausea and vomiting


subject: CHEBI:33283

subject_name: THIAMINE

object_name: Adenomatous colonic polyposis


subject: CHEBI:18385

subject_name: Thiamine


subject: CHEBI:175901

subject_name: Gemcitabine

object_name: Refractory Hodgkin Lymphoma


subject: CHEBI:175901

object_name: Refractory Childhood Hodgkin Lymphoma


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:28748


subject: UNII:3A58010674

subject_name: Pegfilgrastim


subject: UNII:3A58010674


subject: UNII:3A58010674

object_name: Hodgkin Disease


subject: UNII:3A58010674

object_name: Adult Hodgkin Lymphoma


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: PUBCHEM.COMPOUND:44424639

subject_name: Vinorelbine


subject: PUBCHEM.COMPOUND:44424639


subject: PUBCHEM.COMPOUND:44424639


subject: PUBCHEM.COMPOUND:44424639


subject: CHEBI:93786


subject: CHEBI:93786


subject: CHEBI:93786


subject: CHEBI:93786


subject: MESH:C000620716

subject_name: Angong Niuhuang Pill

object_name: stroke disorder


subject: MESH:C000620716

object_name: cerebrovascular disorder


subject: MESH:C000620716

object_name: Stroke (heart beat)


subject: MESH:C000620716

object_name: Stroke, CTCAE


subject: MESH:C000620716

object_name: Acute Ischemic Stroke


subject: MESH:C000620716

object_name: Ischemic stroke


subject: CHEBI:68558

subject_name: Ticagrelor

object_name: brain aneurysm


subject: MESH:D013607

subject_name: Tablets


subject: UMLS:C3897543

subject_name: KX2 391 Ointment

object_name: actinic keratosis


subject: PUBCHEM.COMPOUND:56674991

subject_name: Brincidofovir

object_name: cytomegalovirus infection


subject: CHEBI:6931

subject_name: Midazolam

object_name: anxiety


subject: CHEBI:6931

object_name: anxiety disorder


subject: CHEBI:6931

object_name: Anxiety symptoms


subject: CHEBI:6931

object_name: Anxiety, CTCAE 3.0


subject: CHEBI:6931

object_name: Anxiety, CTCAE 5.0


subject: UNII:L7451S9126

subject_name: Crizanlizumab


subject: PR:000001569

subject_name: P2Y purinoceptor 12


subject: MESH:D000077203

subject_name: Sodium-Glucose Transporter 2 Inhibitors


subject: UMLS:C3542461

subject_name: Sodium-Glucose Cotransporter 2 Inhibitor [EPC]


subject: CHEBI:27732

subject_name: Caffeine

object_name: Dependence


subject: PUBCHEM.COMPOUND:24743758


subject: PUBCHEM.COMPOUND:44424639

object_name: Advanced breast cancer


subject: PUBCHEM.COMPOUND:44424639

object_name: HER2 positive breast carcinoma


subject: CHEBI:93786


subject: CHEBI:93786


subject: CHEMBL.COMPOUND:CHEMBL2108334

subject_name: Coagulation factor VIIa Recombinant Human

object_name: Burn injury


subject: UMLS:C0593103

subject_name: Novoseven


subject: CHEBI:5938

subject_name: Interferon beta-1b

object_name: relapsing-remitting multiple sclerosis


subject: UNII:GN465U8B72

subject_name: Nemolizumab

object_name: atopic eczema


subject: UMLS:C2984024

subject_name: Ferric Carboxymaltose Solution

object_name: Well adult


subject: UMLS:C5203385

subject_name: Ferric Carboxymaltose Liquid Injection


subject: UNII:6897GXD6OE


subject: UMLS:C2346821

subject_name: pidilizumab

object_name: liver carcinoma


subject: UMLS:C1527991

subject_name: Vigil

object_name: Childhood Solid Neoplasm


subject: UMLS:C1527991

object_name: Adult Solid Neoplasm


subject: UMLS:C1527991

object_name: Solid Neoplasm


subject: UMLS:C1527991

object_name: uterine cancer


subject: UMLS:C1527991

object_name: tumor of uterus


subject: UMLS:C1527991

object_name: cervical cancer


subject: UMLS:C1527991

object_name: cervical carcinoma


subject: UMLS:C1527991

object_name: ovarian cancer


subject: UMLS:C1527991

object_name: ovarian neoplasm


subject: UMLS:C1527991

object_name: ovarian carcinoma


subject: UMLS:C1527991

object_name: Metastatic tumors of the Ewing's family


subject: UMLS:C1527991

object_name: Metastatic Ewing's Sarcoma


subject: UMLS:C1527991

object_name: Ewing sarcoma


subject: CHEBI:31859

subject_name: Modafinil


subject: CHEBI:31859


subject: CHEBI:31859


subject: CHEBI:31859


subject: CHEBI:31859


subject: CHEBI:31859


subject: CHEBI:31859


subject: CHEBI:31859


subject: CHEBI:31859


subject: CHEBI:31859


subject: CHEBI:31859


subject: CHEBI:31859


subject: CHEBI:31859


subject: CHEBI:49956

subject_name: Xenon

object_name: no feeling or sensation of skin


subject: CHEBI:49956

object_name: Sensory Loss


subject: UMLS:C0304547

subject_name: Lactobacillus acidophilus preparation

object_name: ischemia


subject: UMLS:C0304547

object_name: Cognitive impairment


subject: UMLS:C0304547

object_name: brain ischemia


subject: CHEMBL.COMPOUND:CHEMBL2109070

subject_name: LACTOBACILLUS ACIDOPHILUS


subject: CHEMBL.COMPOUND:CHEMBL2109070


subject: CHEMBL.COMPOUND:CHEMBL2109070


subject: CHEBI:94789

subject_name: Trimetazidine

object_name: Myocardial injury


subject: CHEBI:94789


subject: CHEBI:94789

object_name: acute respiratory distress syndrome


subject: CHEBI:94789

object_name: adult acute respiratory distress syndrome


subject: PUBCHEM.COMPOUND:135512673

subject_name: Rifampicin

object_name: leprosy


subject: HMDB:HMDB0015179

subject_name: Rifampin


subject: CHEBI:16347

subject_name: Levocarnitine

object_name: multiple sclerosis


subject: UNII:7V6HE3DM5A

subject_name: Ocriplasmin

object_name: uveitis


subject: UNII:7V6HE3DM5A

object_name: Uveitis, CTCAE


subject: UMLS:C1705207

subject_name: Endostar

object_name: pediatric osteosarcoma


subject: UMLS:C1705207

object_name: Osteosarcoma


subject: UMLS:C1705207

object_name: bone cancer


subject: CHEBI:3077

subject_name: Betamethasone


subject: CHEBI:3077

object_name: newborn respiratory distress syndrome


subject: CHEBI:27306

subject_name: vitamin B6

object_name: septic shock


subject: CHEBI:28911

subject_name: cob(III)alamin


subject: PUBCHEM.COMPOUND:165339223

subject_name: Vitamin B 12


subject: HMDB:HMDB0000607

subject_name: Cyanocobalamin


subject: CHEBI:176843

subject_name: vitamin B12


subject: UMLS:C0086024

subject_name: cobalamins


subject: CHEBI:17439


subject: UMLS:C2936883

subject_name: Vitamin B12 [EPC]


subject: CHEBI:38290

subject_name: L-ascorbate


subject: CHEBI:176783

subject_name: vitamin C


subject: UMLS:C3714687

subject_name: Vitamin C Drug Class


subject: UMLS:C2349136

subject_name: Vitamin C Vitamins


subject: CHEBI:22652

subject_name: Ascorbic acid


subject: UMLS:C4522080

subject_name: Vitamin C [EPC]


subject: UNII:6Z3QHB00LB

subject_name: Bimiralisib

object_name: lymphoma


subject: UNII:FU77B4U5Z0

subject_name: Ustekinumab

object_name: cancer


subject: UNII:FU77B4U5Z0

object_name: neoplasm


subject: PR:000006521

subject_name: protein delta homolog 1

object_name: intracerebral hemorrhage


subject: UMLS:C2347529

subject_name: Plant-Derived Hematopoiesis Enhancer PG2


subject: PUBCHEM.COMPOUND:57414794

subject_name: Dolutegravir

object_name: hepatitis C


subject: PUBCHEM.COMPOUND:57414794

object_name: HIV infection


subject: PUBCHEM.COMPOUND:66811198

subject_name: SIMEPREVIR


subject: PUBCHEM.COMPOUND:66811198


subject: CHEBI:2549

subject_name: Albuterol

object_name: asthma


subject: CHEBI:71032

subject_name: Phe-Ser


subject: CHEBI:67271

object_name: Stage I Prostate Cancer AJCC v7


subject: CHEBI:67271

object_name: Stage IIB Prostate Cancer AJCC v7


subject: CHEBI:67271

object_name: Stage III Prostate Cancer AJCC v7


subject: CHEBI:67271

object_name: Stage IIA Prostate Cancer AJCC v7


subject: CHEBI:67271

object_name: Prostate cancer recurrent


subject: UNII:S9I9P4J8IU

object_name: chronic hepatitis B virus infection


subject: UNII:S9I9P4J8IU

object_name: hepatitis B


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: prostate neoplasm


subject: CHEBI:55379

subject_name: camphorsulfonic acid

object_name: pulmonary fibrosis and/or bone marrow failure, Telomere-related, 2


subject: CHEBI:55379

object_name: aplastic anemia


subject: CHEBI:55379

object_name: idiopathic aplastic anemia


subject: PR:000007170

subject_name: DNA excision repair protein ERCC-8


subject: PR:000007170


subject: PR:000007170


subject: PUBCHEM.COMPOUND:135449332

subject_name: Eltrombopag


subject: PUBCHEM.COMPOUND:135449332


subject: PUBCHEM.COMPOUND:135449332


subject: UMLS:C0004149

subject_name: ATGAM


subject: UMLS:C0004149


subject: UMLS:C0004149


subject: CHEBI:70746

subject_name: Dabigatran etexilate

object_name: venous thromboembolism


subject: CHEBI:70746

object_name: thrombophilia due to thrombin defect


subject: CHEBI:70752

subject_name: Dabigatran


subject: CHEBI:70752


subject: CHEBI:44915

subject_name: Propofol

object_name: pain agnosia


subject: CHEBI:44915

object_name: Pain insensitivity


subject: PUBCHEM.COMPOUND:77014446

subject_name: Ketofol


subject: PUBCHEM.COMPOUND:77014446


subject: CHEBI:15361

subject_name: pyruvate

object_name: prostate carcinoma


subject: CHEBI:15361

object_name: prostate cancer


subject: MESH:D011773

subject_name: Pyruvates


subject: MESH:D011773


subject: CHEBI:32816

subject_name: Pyruvic acid


subject: CHEBI:32816


subject: UNII:P0GVQ9A4S5

subject_name: Dostarlimab

object_name: rectal neoplasm


subject: UMLS:C4287697


subject: CHEBI:134892

subject_name: Hexaminolevulinate

object_name: bladder tumor


subject: CHEBI:134892

object_name: urinary bladder carcinoma


subject: CHEBI:134892

object_name: urinary bladder cancer


subject: CHEBI:134892

object_name: childhood bladder carcinoma


subject: UNII:0JSR7Z0NB6

subject_name: Amivantamab

object_name: Neck Carcinoma


subject: UNII:0JSR7Z0NB6

object_name: head and neck neoplasm


subject: UNII:0JSR7Z0NB6

object_name: head and neck cancer


subject: UNII:0JSR7Z0NB6

object_name: non-small cell lung carcinoma


subject: UNII:0JSR7Z0NB6

object_name: gastroesophageal cancer


subject: UNII:0JSR7Z0NB6

object_name: pancreatic neoplasm


subject: UNII:0JSR7Z0NB6

object_name: exocrine pancreatic carcinoma


subject: UNII:0JSR7Z0NB6

object_name: malignant pancreatic neoplasm


subject: UNII:0JSR7Z0NB6

object_name: colorectal cancer


subject: UNII:0JSR7Z0NB6

object_name: colorectal carcinoma


subject: UNII:0JSR7Z0NB6

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UNII:0JSR7Z0NB6

object_name: ovarian cancer


subject: UNII:0JSR7Z0NB6

object_name: ovarian neoplasm


subject: UNII:0JSR7Z0NB6

object_name: ovarian carcinoma


subject: UNII:0JSR7Z0NB6

object_name: Childhood Breast Carcinoma


subject: UNII:0JSR7Z0NB6

object_name: breast carcinoma


subject: UNII:0JSR7Z0NB6

object_name: breast cancer


subject: UMLS:C4085970

object_name: Neck Carcinoma


subject: UMLS:C4085970

object_name: head and neck neoplasm


subject: UMLS:C4085970

object_name: head and neck cancer


subject: UMLS:C4085970

object_name: non-small cell lung carcinoma


subject: UMLS:C4085970

object_name: gastroesophageal cancer


subject: UMLS:C4085970

object_name: pancreatic neoplasm


subject: UMLS:C4085970

object_name: exocrine pancreatic carcinoma


subject: UMLS:C4085970

object_name: malignant pancreatic neoplasm


subject: UMLS:C4085970

object_name: colorectal cancer


subject: UMLS:C4085970

object_name: colorectal carcinoma


subject: UMLS:C4085970

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C4085970

object_name: ovarian cancer


subject: UMLS:C4085970

object_name: ovarian neoplasm


subject: UMLS:C4085970

object_name: ovarian carcinoma


subject: UMLS:C4085970

object_name: Childhood Breast Carcinoma


subject: UMLS:C4085970

object_name: breast carcinoma


subject: UMLS:C4085970

object_name: breast cancer


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: Neck Carcinoma


subject: UNII:52CMI0WC3Y

object_name: head and neck neoplasm


subject: UNII:52CMI0WC3Y

object_name: head and neck cancer


subject: UNII:52CMI0WC3Y


subject: UNII:52CMI0WC3Y


subject: UNII:52CMI0WC3Y


subject: UNII:52CMI0WC3Y


subject: UNII:52CMI0WC3Y


subject: UNII:52CMI0WC3Y


subject: UNII:52CMI0WC3Y


subject: UNII:52CMI0WC3Y


subject: UNII:52CMI0WC3Y


subject: UNII:52CMI0WC3Y


subject: UNII:52CMI0WC3Y


subject: UNII:52CMI0WC3Y


subject: UNII:52CMI0WC3Y


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UNII:KXG2PJ551I

subject_name: Avelumab


subject: UNII:KXG2PJ551I


subject: UNII:KXG2PJ551I


subject: UNII:KXG2PJ551I


subject: UNII:KXG2PJ551I


subject: UNII:KXG2PJ551I


subject: UNII:KXG2PJ551I


subject: UNII:KXG2PJ551I


subject: UNII:KXG2PJ551I


subject: UNII:KXG2PJ551I


subject: UNII:KXG2PJ551I


subject: UNII:KXG2PJ551I


subject: UNII:KXG2PJ551I


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UNII:PQX0D8J21J

subject_name: Cetuximab


subject: UNII:PQX0D8J21J


subject: UNII:PQX0D8J21J


subject: UNII:PQX0D8J21J


subject: UNII:PQX0D8J21J


subject: UNII:PQX0D8J21J


subject: UNII:PQX0D8J21J


subject: UNII:PQX0D8J21J


subject: UNII:PQX0D8J21J


subject: UNII:PQX0D8J21J


subject: UMLS:C0879636

subject_name: IMC C225


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: GTOPDB:4985


subject: GTOPDB:4985


subject: GTOPDB:4985


subject: GTOPDB:4985

object_name: non-small cell lung carcinoma


subject: GTOPDB:4985

object_name: gastroesophageal cancer


subject: GTOPDB:4985

object_name: pancreatic neoplasm


subject: GTOPDB:4985

object_name: exocrine pancreatic carcinoma


subject: GTOPDB:4985

object_name: malignant pancreatic neoplasm


subject: GTOPDB:4985

object_name: colorectal cancer


subject: GTOPDB:4985

object_name: colorectal carcinoma


subject: GTOPDB:4985

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: GTOPDB:4985


subject: GTOPDB:4985


subject: GTOPDB:4985


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: UMLS:C5139755

subject_name: Human interleukin-2


subject: UMLS:C5139755


subject: UMLS:C5139755


subject: UMLS:C5139755


subject: UMLS:C5139755


subject: UMLS:C5139755


subject: UMLS:C5139755


subject: UMLS:C5139755


subject: UMLS:C5139755


subject: UMLS:C5139755


subject: UMLS:C5139755


subject: UMLS:C5139755


subject: UMLS:C5139755


subject: UMLS:C5139755


subject: CHEBI:231614

subject_name: Nivolumab


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614

object_name: ovarian cancer


subject: CHEBI:231614

object_name: ovarian neoplasm


subject: CHEBI:231614

object_name: ovarian carcinoma


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: CHEBI:231601

subject_name: trastuzumab


subject: CHEBI:231601


subject: CHEBI:231601


subject: CHEBI:231601


subject: CHEBI:231601


subject: CHEBI:231601


subject: CHEBI:231601


subject: CHEBI:231601


subject: CHEBI:231601


subject: CHEBI:231601


subject: CHEBI:231601


subject: CHEBI:231601


subject: CHEBI:231601


subject: CHEBI:231601


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UMLS:C0338204

subject_name: Herceptin


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: CHEBI:177298

object_name: nonpapillary renal cell carcinoma


subject: CHEBI:177298

object_name: clear cell renal carcinoma


subject: CHEBI:177298

object_name: renal cell adenocarcinoma


subject: CHEBI:177298

object_name: renal cell carcinoma


subject: CHEBI:177298

object_name: cholangiocarcinoma


subject: CHEBI:177298

object_name: Mesothelioma


subject: CHEBI:177298

object_name: mesothelial neoplasm


subject: CHEBI:177298

object_name: malignant mesothelioma


subject: CHEBI:177298

object_name: uveal melanoma


subject: CHEBI:176844

subject_name: Niraparib


subject: CHEBI:176844


subject: CHEBI:176844


subject: CHEBI:176844


subject: CHEBI:176844


subject: CHEBI:176844


subject: CHEBI:176844


subject: CHEBI:176844


subject: CHEBI:176844


subject: CHEBI:73272

subject_name: CANAGLIFLOZIN

object_name: type 2 diabetes mellitus


subject: CHEBI:73272

object_name: Confusion


subject: PUBCHEM.COMPOUND:74323022

subject_name: Canagliflozin


subject: PUBCHEM.COMPOUND:74323022


subject: PUBCHEM.COMPOUND:11306691

subject_name: rac-Sitagliptin


subject: CHEBI:40237

subject_name: Sitagliptin


subject: CHEBI:63925

subject_name: PhXa 85

object_name: glaucoma


subject: CHEBI:63925

object_name: Glaucoma, CTCAE


subject: UMLS:C0445115

subject_name: Normal saline

object_name: Postoperative Complications


subject: CHEBI:94518

subject_name: Tranexamic acid


subject: UMLS:C0718234

subject_name: Acthar

object_name: rheumatoid arthritis


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina

object_name: optic neuritis


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: UMLS:C3265062


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:16958

subject_name: beta-Alanine

object_name: Cognitive impairment


subject: UMLS:C0000392

subject_name: beta-alanine


subject: CHEBI:63629

subject_name: Tizanidine

object_name: stroke disorder


subject: CHEBI:63629

object_name: cerebrovascular disorder


subject: CHEBI:63629

object_name: Stroke (heart beat)


subject: CHEBI:63629

object_name: Stroke, CTCAE


subject: DRUGBANK:DB15803

subject_name: Dendritic cells vaccine

object_name: skin melanoma


subject: CHEBI:6129

subject_name: Ketorolac

object_name: opioid use


subject: CHEBI:6129

object_name: plasma cell myeloma


subject: CHEBI:6129

object_name: Metastatic malignant neoplasm to bone


subject: CHEBI:6129

object_name: adult lymphoma


subject: CHEBI:6129

object_name: lymphoma


subject: CHEBI:6129

object_name: pediatric lymphoma


subject: UNII:15C2VL427D

subject_name: Aflibercept

object_name: wet macular degeneration


subject: CHEBI:2549

subject_name: Albuterol

object_name: chronic obstructive pulmonary disease


subject: CHEBI:2549

object_name: chronic bronchitis


subject: CHEBI:2549

object_name: bronchitis


subject: CHEBI:2549

object_name: emphysema


subject: UniProtKB:Q6PDA7

subject_name: SG11A_HUMAN Sperm-associated antigen 11A (sprot)

object_name: classic familial adenomatous polyposis


subject: UniProtKB:Q6PDA7

object_name: Adenomatous colonic polyposis


subject: PR:000015454

subject_name: sperm-associated antigen 11B


subject: PR:000015454


subject: PR:000015453

subject_name: sperm-associated antigen 11A


subject: PR:000015453


subject: UniProtKB:Q08648

subject_name: SG11B_HUMAN Sperm-associated antigen 11B (sprot)


subject: UniProtKB:Q08648


subject: CHEBI:74705

subject_name: Met-Leu

object_name: kidney failure


subject: CHEBI:74705

object_name: type 2 diabetes mellitus


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000009425


subject: PR:000016318

subject_name: thrombopoietin


subject: PR:000016318


subject: UNII:7511RY999U


subject: UMLS:C3886675

object_name: pulmonary hypertension


subject: UMLS:C3886675

object_name: Pulmonary Hypertension, CTCAE


subject: CHEBI:50861

subject_name: Treprostinil


subject: UNII:8M7YSN2KII

subject_name: nortramadol

object_name: Alzheimer disease


subject: CHEBI:51112


subject: CHEBI:34827


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: UniProtKB:P15379-4

subject_name: CD44 antigen isoform 4 (mouse)


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: bladder tumor


subject: UNII:DPT0O3T46P

object_name: urinary bladder carcinoma


subject: UNII:DPT0O3T46P

object_name: urinary bladder cancer


subject: UNII:DPT0O3T46P

object_name: childhood bladder carcinoma


subject: PUBCHEM.COMPOUND:9891967

subject_name: Silodosin

object_name: benign prostatic hyperplasia


subject: PR:000014196

subject_name: eukaryotic-type large ribosomal subunit protein uL22

object_name: Metastatic Malignant Solid Neoplasm


subject: PR:000001919

subject_name: programmed cell death protein 1


subject: UMLS:C5392068

subject_name: PD-L1 Inhibitors


subject: UMLS:C5784959

subject_name: SHP2 Inhibitor ET0038

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: Acute Pain


subject: CHEBI:3215

object_name: Chest pain


subject: UMLS:C0021658

subject_name: Humulin N

object_name: hyperglycemia


subject: UMLS:C0021658

object_name: Hyperglycemia, CTCAE


subject: UMLS:C0021658

object_name: Glucose in blood specimen above reference range


subject: UMLS:C0304870

subject_name: Insulin, Long-Acting


subject: UMLS:C0304870


subject: UMLS:C0304870


subject: CHEBI:188986

subject_name: idose

object_name: glaucoma


subject: CHEBI:188986

object_name: Glaucoma, CTCAE


subject: CHEBI:3176

subject_name: Brinzolamide


subject: CHEBI:3176


subject: CHEBI:48923

subject_name: erythromycin

object_name: Upper gastrointestinal hemorrhage


subject: CHEBI:42355

subject_name: Erythromycin


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: cancer


subject: CHEBI:4026

object_name: neoplasm


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: PUBCHEM.COMPOUND:3368

subject_name: Fludara


subject: PUBCHEM.COMPOUND:3368


subject: UMLS:C0700805


subject: UMLS:C0700805


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:231679

subject_name: ipilimumab


subject: CHEBI:231679


subject: UNII:M89N0Q7EQR

subject_name: Aldesleukin


subject: UNII:M89N0Q7EQR


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide

object_name: acute lymphoblastic leukemia


subject: CHEBI:28680

subject_name: Cytarabine


subject: CHEBI:94265

subject_name: Cerubidin


subject: CHEBI:64677

subject_name: Cerubidine


subject: CHEBI:41977

subject_name: Daunorubicin


subject: CHEBI:41879

subject_name: Dexamethasone


subject: CHEBI:93775

subject_name: Amethopterin


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: UNII:7D96IR0PPM

subject_name: Pegaspargase


subject: CHEBI:8382

subject_name: Prednisone


subject: CHEBI:143658


subject: CHEBI:28445

subject_name: vincristine


subject: UNII:PE152PYI6M

object_name: coronary artery disorder


subject: UNII:PE152PYI6M

object_name: coronary atherosclerosis


subject: UNII:PE152PYI6M

object_name: hypertension


subject: UNII:PE152PYI6M

object_name: Hypertension, CTCAE


subject: UNII:PE152PYI6M

object_name: inherited lipid metabolism disorder


subject: UNII:PE152PYI6M

object_name: Dyslipidemia


subject: UNII:PE152PYI6M

object_name: type 2 diabetes mellitus


subject: UNII:PE152PYI6M

object_name: Diabetes


subject: UNII:PE152PYI6M

object_name: diabetes mellitus


subject: UMLS:C3818952

subject_name: magnesium L-lactate


subject: UMLS:C3818952


subject: UMLS:C3818952


subject: UMLS:C3818952


subject: UMLS:C3818952


subject: UMLS:C3818952


subject: UMLS:C3818952


subject: UMLS:C3818952


subject: UMLS:C3818952


subject: UMLS:C3896762

object_name: Disseminated Malignant Neoplasm


subject: UMLS:C3896762

object_name: Embolism, Tumor


subject: UMLS:C3896762

object_name: Neoplasm Metastasis


subject: UMLS:C3896762

object_name: metastatic neoplasm


subject: UMLS:C3896762

object_name: Metastatic Lesion


subject: UMLS:C3896762

object_name: Carcinoma breast stage IV


subject: UMLS:C3896762

object_name: ovarian cancer


subject: UMLS:C3896762

object_name: ovarian neoplasm


subject: UMLS:C3896762

object_name: ovarian carcinoma


subject: UMLS:C3896762

object_name: bladder tumor


subject: UMLS:C3896762

object_name: urinary bladder carcinoma


subject: UMLS:C3896762

object_name: urinary bladder cancer


subject: UMLS:C3896762

object_name: childhood bladder carcinoma


subject: UMLS:C3896762

object_name: HER2-positive gastric cancer


subject: UMLS:C3896762

object_name: Metastatic Digestive System Neuroendocrine Tumor G1


subject: UMLS:C3896762

object_name: metastatic gastrointestinal carcinoid tumor


subject: UMLS:C3896762

object_name: HER2 low breast cancer


subject: UMLS:C3896762

object_name: gastroesophageal cancer


subject: UMLS:C3896762

object_name: HER2 positive breast carcinoma


subject: UMLS:C3896762

object_name: progesterone-receptor positive breast cancer


subject: UMLS:C3896762

object_name: hormone receptor-positive breast cancer


subject: UMLS:C3896762

object_name: triple-negative breast carcinoma


subject: UMLS:C3896762

object_name: Triple-Negative Breast Cancer Finding


subject: UMLS:C3896762

object_name: Hormone Receptor-Negative Breast Carcinoma


subject: UMLS:C3896762

object_name: gastroesophageal adenocarcinoma


subject: UMLS:C3896762

object_name: Estrogen receptor positive tumor


subject: UMLS:C3896762

object_name: ERBB2 mutation-related tumors


subject: UMLS:C3896762

object_name: HER2 protein overexpression


subject: UMLS:C3896762

object_name: endometrium neoplasm


subject: UMLS:C3896762

object_name: malignant epithelial tumor of ovary


subject: CHEBI:45863

subject_name: Paclitaxel

object_name: Disseminated Malignant Neoplasm


subject: CHEBI:45863

object_name: Embolism, Tumor


subject: CHEBI:45863

object_name: Neoplasm Metastasis


subject: CHEBI:45863

object_name: metastatic neoplasm


subject: CHEBI:45863

object_name: Metastatic Lesion


subject: CHEBI:45863

object_name: Carcinoma breast stage IV


subject: CHEBI:45863

object_name: bladder tumor


subject: CHEBI:45863

object_name: urinary bladder carcinoma


subject: CHEBI:45863

object_name: urinary bladder cancer


subject: CHEBI:45863

object_name: childhood bladder carcinoma


subject: CHEBI:45863

object_name: HER2-positive gastric cancer


subject: CHEBI:45863

object_name: Metastatic Digestive System Neuroendocrine Tumor G1


subject: CHEBI:45863

object_name: metastatic gastrointestinal carcinoid tumor


subject: CHEBI:45863

object_name: HER2 low breast cancer


subject: CHEBI:45863

object_name: gastroesophageal cancer


subject: CHEBI:45863

object_name: HER2 positive breast carcinoma


subject: CHEBI:45863

object_name: progesterone-receptor positive breast cancer


subject: CHEBI:45863

object_name: hormone receptor-positive breast cancer


subject: CHEBI:45863

object_name: Hormone Receptor-Negative Breast Carcinoma


subject: CHEBI:45863

object_name: gastroesophageal adenocarcinoma


subject: CHEBI:45863

object_name: Estrogen receptor positive tumor


subject: CHEBI:45863

object_name: ERBB2 mutation-related tumors


subject: CHEBI:45863

object_name: HER2 protein overexpression


subject: CHEBI:45863

object_name: endometrium neoplasm


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: Dyslipidemia


subject: CHEBI:41879

object_name: diabetes mellitus


subject: CHEBI:230430

subject_name: Ulinastatin

object_name: Postoperative cognitive dysfunction


subject: CHEBI:230430

object_name: Postoperative delirium


subject: CHEBI:230430

object_name: Emergence Delirium


subject: UNII:OR3S9IF86U

subject_name: urinastatin


subject: UNII:OR3S9IF86U


subject: UNII:OR3S9IF86U


subject: CHEMBL.COMPOUND:CHEMBL2108163

subject_name: ULINASTATIN


subject: CHEMBL.COMPOUND:CHEMBL2108163


subject: CHEMBL.COMPOUND:CHEMBL2108163


subject: UMLS:C0077906


subject: UMLS:C0077906


subject: UMLS:C0077906


subject: GTOPDB:13484

subject_name: palopegteriparatide

object_name: hypoparathyroidism


subject: GTOPDB:13484

object_name: Hypoparathyroidism, CTCAE


subject: UNII:G2N64C3385

subject_name: PALOPEGTERIPARATIDE


subject: UNII:G2N64C3385


subject: CHEBI:135983

subject_name: Teriparatide


subject: CHEBI:135983


subject: UMLS:C5557539


subject: UMLS:C5557539


subject: UMLS:C5945086

subject_name: TransCon PTH


subject: UMLS:C5945086


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: Parkinson disease


subject: UMLS:C4086713

subject_name: Substance with programmed cell death protein 1 inhibitor mechanism of action (substance)

object_name: Plaque, Atherosclerotic


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: lung cancer


subject: UNII:2S9ZZM9Q9V

object_name: lung neoplasm


subject: UNII:2S9ZZM9Q9V

object_name: lung carcinoma


subject: CHEBI:52717

subject_name: Bortezomib


subject: CHEBI:52717


subject: CHEBI:52717


subject: CHEBI:9356

subject_name: Sultopride

object_name: Post-schizophrenic depression


subject: CHEBI:64045

subject_name: Amisulpride


subject: CHEBI:135047

subject_name: Phenyltoloxamine

object_name: Myopic choroidal neovascularization


subject: PR:000010988

subject_name: cytosolic iron-sulfur assembly component 3


subject: UniProtKB:P14283

subject_name: PERT_BORPE Pertactin autotransporter (sprot)


subject: CHEBI:32599

object_name: Knee arthropathy


subject: CHEBI:32599

object_name: cortisol measurement


subject: CHEBI:229223

subject_name: Daprodustat

object_name: anemia


subject: UMLS:C4043356


subject: CHEBI:93274

subject_name: Fluvoxamine


subject: UMLS:C2986991

subject_name: VEGFR2-targeted Contrast Agent BR55

object_name: ovarian cancer


subject: UMLS:C2986991

object_name: ovarian neoplasm


subject: UMLS:C2986991

object_name: ovarian carcinoma


subject: CHEBI:46058

subject_name: TAXOTERE


subject: CHEBI:46058


subject: CHEBI:46058


subject: CHEBI:32296

subject_name: vinorelbine L-tartrate


subject: CHEBI:32296


subject: CHEBI:32296


subject: PUBCHEM.COMPOUND:16051941


subject: PUBCHEM.COMPOUND:16051941


subject: PUBCHEM.COMPOUND:16051941


subject: CHEBI:53750

subject_name: vinorelbine D-tartrate


subject: CHEBI:53750


subject: CHEBI:53750


subject: PUBCHEM.COMPOUND:44424639

subject_name: Vinorelbine


subject: PUBCHEM.COMPOUND:44424639


subject: PUBCHEM.COMPOUND:44424639


subject: CHEBI:93786


subject: CHEBI:93786


subject: CHEBI:93786


subject: PUBCHEM.COMPOUND:25136944

subject_name: Navelbine


subject: PUBCHEM.COMPOUND:25136944


subject: PUBCHEM.COMPOUND:25136944


subject: UNII:D6OMY2L0WA

subject_name: Epcoritamab

object_name: follicular lymphoma


subject: UNII:D6OMY2L0WA

object_name: adult lymphoma


subject: UNII:D6OMY2L0WA

object_name: lymphoma


subject: UNII:D6OMY2L0WA

object_name: pediatric lymphoma


subject: UNII:D6OMY2L0WA

object_name: Adult Non-Hodgkin Lymphoma


subject: UNII:D6OMY2L0WA

object_name: lymphoma, non-Hodgkin, familial


subject: UNII:D6OMY2L0WA

object_name: non-Hodgkin lymphoma


subject: UNII:D6OMY2L0WA

object_name: Childhood Non-Hodgkin Lymphoma


subject: UMLS:C5206892

subject_name: epcoritamab


subject: UMLS:C5206892


subject: UMLS:C5206892


subject: UMLS:C5206892


subject: UMLS:C5206892


subject: UMLS:C5206892


subject: UMLS:C5206892


subject: UMLS:C5206892


subject: CHEBI:172944

subject_name: Cabotegravir

object_name: HIV-1 infection


subject: CHEBI:68606

subject_name: Rilpivirine


subject: PUBCHEM.COMPOUND:66586232

object_name: bacterial infectious disease


subject: CHEBI:3614

subject_name: Chlorhexidine


subject: CHEBI:72296

subject_name: Apixaban

object_name: atrial fibrillation


subject: CHEBI:72296

object_name: Atrial Fibrillation by ECG Finding


subject: CHEBI:72296

object_name: Atrial Fibrillation, CTCAE


subject: UNII:PP0SHH6V16

subject_name: Alirocumab

object_name: Acute Ischemic Stroke


subject: UNII:PP0SHH6V16

object_name: Ischemic stroke


subject: UNII:PP0SHH6V16

object_name: Intracranial Atherosclerosis


subject: UNII:PP0SHH6V16

object_name: cerebral atherosclerosis


subject: CHEBI:232556

subject_name: Erdafitinib

object_name: ovarian cancer


subject: CHEBI:232556

object_name: ovarian neoplasm


subject: CHEBI:232556

object_name: ovarian carcinoma


subject: CHEBI:232556

object_name: Malignant Ovarian Steroid Cell Tumor


subject: CHEBI:232556

object_name: Steroid cell tumor, malignant


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: malignant glioma


subject: UNII:2S9ZZM9Q9V

object_name: Adult Gliosarcoma


subject: UNII:2S9ZZM9Q9V

object_name: gliosarcoma


subject: UNII:2S9ZZM9Q9V

object_name: Childhood Gliosarcoma


subject: UNII:2S9ZZM9Q9V

object_name: glioblastoma


subject: UNII:2S9ZZM9Q9V

object_name: Childhood Glioblastoma


subject: UNII:2S9ZZM9Q9V

object_name: adult glioblastoma


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED


subject: UMLS:C0919079


subject: UMLS:C0919079


subject: CHEBI:72564

subject_name: Temozolomide


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:63632

subject_name: Topotecan


subject: CHEBI:63632


subject: CHEBI:63632


subject: CHEBI:63632


subject: CHEBI:63632


subject: CHEBI:63632


subject: CHEBI:63632


subject: UNII:N5UK68MGDZ

subject_name: Apremilast

object_name: psoriatic arthritis


subject: PUBCHEM.COMPOUND:66586232

object_name: gingivitis


subject: CHEBI:3614


subject: UNII:L500PR95QA

subject_name: METRONIDAZOLE PHOSPHATE


subject: CHEBI:6909

subject_name: Metronidazole


subject: UNII:GKF8S4C432

subject_name: Anlotinib

object_name: non-small cell lung carcinoma


subject: UNII:GKF8S4C432

object_name: squamous cell carcinoma


subject: UNII:GKF8S4C432

object_name: esophageal adenocarcinoma


subject: UNII:GKF8S4C432

object_name: lung adenocarcinoma


subject: UNII:GKF8S4C432

object_name: cervical adenocarcinoma


subject: UNII:GKF8S4C432

object_name: adenocarcinoma


subject: UNII:GKF8S4C432

object_name: bile duct adenocarcinoma


subject: UNII:GKF8S4C432

object_name: gastric adenocarcinoma


subject: CHEBI:31355

subject_name: Carboplatin


subject: CHEBI:31355


subject: CHEBI:31355


subject: CHEBI:31355


subject: CHEBI:31355


subject: CHEBI:4875

subject_name: Etanercept

object_name: myocardial infarction


subject: CHEBI:4875

object_name: Myocardial Infarction, CTCAE


subject: CHEBI:4875

object_name: Myocardial Infarction by ECG Finding


subject: PR:000001959

subject_name: tumor necrosis factor receptor superfamily member 1B


subject: PR:000001959


subject: PR:000001959


subject: CHEBI:64220

subject_name: monosodium glutamate

object_name: Heartburn


subject: CHEBI:16015

subject_name: Glutamic acid


subject: UMLS:C0037511

subject_name: sodium glutamate


subject: CHEBI:135005

subject_name: Milnacipran

object_name: Fibromyalgia, Primary


subject: UMLS:C2935150

subject_name: solanezumab

object_name: Alzheimer disease


subject: CHEBI:91400

subject_name: Afatinib

object_name: liver disorder


subject: UNII:7UP768IP4M

object_name: neuralgia


subject: UNII:7UP768IP4M

object_name: Neuropathic pain


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Melanoma recurrent


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: CHEBI:135983

subject_name: Teriparatide

object_name: osteoporosis


subject: CHEBI:135983

object_name: Encounter due to family history of osteoporosis


subject: CHEBI:135983

object_name: Osteoporosis, CTCAE 5.0


subject: CHEBI:135983

object_name: Osteoporosis, CTCAE 3.0


subject: CHEMBL.COMPOUND:CHEMBL2108015

subject_name: VITAMIN B COMPLEX

object_name: acute kidney failure


subject: CHEMBL.COMPOUND:CHEMBL2108015

object_name: Acute Kidney Injury, CTCAE


subject: CHEBI:8768

subject_name: Rabeprazole

object_name: Gastroesophageal Reflux Disease, CTCAE


subject: PUBCHEM.COMPOUND:49849451

subject_name: Anacetrapib

object_name: coronary artery disorder


subject: UMLS:C0003921

subject_name: artificial tears (medication)

object_name: Eye Injuries


subject: UMLS:C2608262

subject_name: Lubricant Eye Drops


subject: UMLS:C3853661

subject_name: Artificial Tears


subject: PUBCHEM.COMPOUND:58008990

subject_name: Duvelisib

object_name: follicular lymphoma


subject: PUBCHEM.COMPOUND:58008990

object_name: marginal zone lymphoma


subject: PUBCHEM.COMPOUND:58008990

object_name: MALT lymphoma


subject: PUBCHEM.COMPOUND:58008990

object_name: primary cutaneous peripheral T-cell lymphoma not otherwise specified


subject: PUBCHEM.COMPOUND:58008990

object_name: chronic lymphocytic leukemia/small lymphocytic lymphoma


subject: PUBCHEM.COMPOUND:58008990

object_name: diffuse large B-cell lymphoma


subject: PUBCHEM.COMPOUND:58008990

object_name: Richter syndrome


subject: UNII:R8DG7T2D3A

subject_name: FERUMOXYTOL

object_name: iron deficiency anemia


subject: UNII:CLH5FT6412

subject_name: Ferumoxytol


subject: CHEBI:46726

subject_name: magnetite


subject: PUBCHEM.COMPOUND:16131310

subject_name: Hepatitis B Vaccines

object_name: hepatitis B


subject: DRUGBANK:DB11627

subject_name: Hepatitis B Vaccine (Recombinant)


subject: UMLS:C2240392


subject: UMLS:C0062527

subject_name: Engerix-B


subject: CHEBI:8405

subject_name: Primaquine

object_name: malaria


subject: CHEBI:41500

subject_name: Phenylbutyrates

object_name: D,L-2-hydroxyglutaric aciduria


subject: UNII:UU226QGU97

subject_name: Imeglimin

object_name: type 2 diabetes mellitus


subject: CHEBI:38545

subject_name: Rosuvastatin


subject: CHEBI:23359

subject_name: colchicine


subject: CHEBI:4672

subject_name: Docetaxel

object_name: Carcinoma breast stage IV


subject: UMLS:C4331834

subject_name: Agonistic Anti-OX40 Monoclonal Antibody INCAGN01949

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: UMLS:C4331834

object_name: Pancreatic adenocarcinoma metastatic


subject: UMLS:C4331834

object_name: Locally Advanced Malignant Solid Neoplasm


subject: UMLS:C4331834

object_name: Unresectable Malignant Solid Neoplasm


subject: UMLS:C4287773

subject_name: VLP-encapsulated TLR9 Agonist CMP-001


subject: UMLS:C4287773


subject: UMLS:C4287773


subject: UMLS:C4287773


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: post operative nausea and vomiting


subject: CHEBI:499361

subject_name: Aprepitant


subject: UMLS:C0699857

subject_name: Nitrate

object_name: coronary microvascular disorder


subject: CHEBI:17632


subject: CHEBI:48107

subject_name: Nitric acid


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: nephrolithiasis


subject: CHEBI:41774

subject_name: Tamoxifen

object_name: ovarian cancer


subject: CHEBI:41774

object_name: ovarian neoplasm


subject: CHEBI:41774

object_name: ovarian carcinoma


subject: CHEBI:41774

object_name: fallopian tube carcinoma


subject: CHEBI:41774

object_name: fallopian tube cancer


subject: CHEBI:41774

object_name: peritoneum cancer


subject: CHEBI:9150

subject_name: Simvastatin

object_name: Plasma cell myeloma refractory


subject: CHEBI:9150

object_name: Plasma cell myeloma recurrent


subject: UNII:T4H8FMA7IM

subject_name: Siltuximab

object_name: plasma cell myeloma


subject: PUBCHEM.COMPOUND:3005

subject_name: Dexamethasone palmitate


subject: UNII:328C4R3P9L

subject_name: Retagliptin

object_name: type 2 diabetes mellitus


subject: UMLS:C0770246

subject_name: PROTEIN SUPPLEMENTS


subject: CHEMBL.COMPOUND:CHEMBL3833369

subject_name: FISH OIL

object_name: cardiac conduction defect


subject: CHEMBL.COMPOUND:CHEMBL3833369

object_name: ventricular tachycardia


subject: CHEMBL.COMPOUND:CHEMBL3833369

object_name: Ventricular Tachycardia, CTCAE 3.0


subject: CHEMBL.COMPOUND:CHEMBL3833369

object_name: continuous electrocardiogram ventricular tachycardia


subject: CHEMBL.COMPOUND:CHEMBL3833369

object_name: Ventricular Tachycardia by ECG Finding


subject: CHEMBL.COMPOUND:CHEMBL3833369

object_name: Ventricular Tachycardia, CTCAE 5.0


subject: CHEBI:45783

subject_name: Imatinib

object_name: rheumatoid arthritis


subject: CHEBI:63611

subject_name: Moxifloxacin

object_name: pneumonia


subject: CHEBI:63611

object_name: COVID-19-Associated Pneumonia


subject: CHEMBL.COMPOUND:CHEMBL2109465

object_name: eosinophilic esophagitis


subject: CHEMBL.COMPOUND:CHEMBL2109465

object_name: Eosinophilic infiltration of the esophagus


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus

object_name: endometrial cancer


subject: PUBCHEM.COMPOUND:70789204

object_name: uterine corpus cancer


subject: PUBCHEM.COMPOUND:70789204

object_name: endometrial carcinoma


subject: CHEBI:6801

subject_name: Metformin


subject: CHEBI:6801


subject: CHEBI:6801


subject: UMLS:C3537001

subject_name: ALT 711

object_name: heart failure


subject: CHEBI:4806

subject_name: Epigallocatechin gallate

object_name: small cell lung carcinoma


subject: PUBCHEM.COMPOUND:3663

subject_name: hypericin

object_name: HIV infection


subject: CHEBI:5835

subject_name: Hypericin


subject: PUBCHEM.COMPOUND:53477758

subject_name: Oxytocin

object_name: Tinnitus


subject: PUBCHEM.COMPOUND:53477758

object_name: Tinnitus, CTCAE 5.0


subject: PUBCHEM.COMPOUND:53477758

object_name: Tinnitus, CTCAE 3.0


subject: UMLS:C0592155

subject_name: Syntocinon


subject: UMLS:C0592155


subject: UMLS:C0592155


subject: UNII:7SE5582Q2P

subject_name: Vosoritide

object_name: Dwarfism


subject: UNII:7SE5582Q2P

object_name: Short stature


subject: UNII:7SE5582Q2P

object_name: Short Stature, CTCAE


subject: UMLS:C4308782

object_name: rheumatoid arthritis


subject: CHEBI:3738

subject_name: Clemastine

object_name: Neurodevelopmental delay


subject: CHEBI:3738

object_name: Williams syndrome


subject: CHEBI:3738

object_name: primary interstitial lung disease specific to childhood


subject: CHEBI:3738

object_name: interstitial lung disease specific to childhood


subject: CHEBI:63578

subject_name: Iopromide

object_name: chronic kidney disease


subject: CHEBI:63578

object_name: Chronic uremia


subject: UMLS:C0728741

subject_name: Ultravist


subject: UMLS:C0728741


subject: UMLS:C4331423

subject_name: Traditional Chinese Medicine Formulation

object_name: dry eye syndrome


subject: UMLS:C4331423

object_name: Dry Eye, CTCAE


subject: UMLS:C4331423

object_name: Dryness of eye


subject: CHEBI:64816

object_name: Childhood Breast Carcinoma


subject: CHEBI:64816

object_name: breast carcinoma


subject: CHEBI:64816

object_name: breast cancer


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:84500

subject_name: varenicline

object_name: Marijuana Use


subject: CHEBI:84500

object_name: Cannabis use


subject: CHEBI:84500

object_name: Cannabis use disorder


subject: CHEBI:38940

subject_name: Sunitinib

object_name: carcinoma of urethra


subject: CHEBI:38940

object_name: urethra cancer


subject: CHEBI:38940

object_name: renal pelvis/ureter urothelial carcinoma


subject: CHEBI:38940

object_name: bladder tumor


subject: CHEBI:38940

object_name: urinary bladder carcinoma


subject: CHEBI:38940

object_name: urinary bladder cancer


subject: CHEBI:38940

object_name: childhood bladder carcinoma


subject: UMLS:C4723628

subject_name: A-101 Topical Solution

object_name: common wart


subject: UNII:97S8U912UG

subject_name: GLIAL GROWTH FACTOR 2

object_name: heart failure


subject: UNII:97S8U912UG

object_name: Heart Failure, CTCAE


subject: UMLS:C4319619

subject_name: Glial growth factor 2


subject: UMLS:C4319619


subject: UMLS:C3896931

object_name: Leukemia, Myeloid, Chronic-Phase


subject: UMLS:C5203926

subject_name: EZH2 Inhibitor SHR2554

object_name: mature T-cell and NK-cell non-Hodgkin lymphoma


subject: UMLS:C5203926

object_name: primary cutaneous peripheral T-cell lymphoma not otherwise specified


subject: CHEBI:18132

subject_name: phosphocholine


subject: CHEBI:18132


subject: UniProtKB:Q62857

subject_name: DDIT3_RAT DNA damage-inducible transcript 3 protein (sprot)


subject: UniProtKB:Q62857


subject: PR:000006347

subject_name: DNA damage-inducible transcript 3 protein


subject: PR:000006347


subject: PUBCHEM.COMPOUND:444033

subject_name: Ciclesonide

object_name: asthma


subject: CHEBI:190738

subject_name: Demethylated antipyrine

object_name: Brain necrosis


subject: CHEBI:190738

object_name: nasopharyngeal carcinoma


subject: CHEBI:190738

object_name: nasopharyngeal carcinoma, susceptibility to, 1


subject: UNII:S798V6YJRP

subject_name: EDARAVONE


subject: UNII:S798V6YJRP


subject: UNII:S798V6YJRP


subject: CHEBI:31530

subject_name: Edaravone


subject: CHEBI:31530


subject: CHEBI:31530


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: metastatic colorectal cancer


subject: UNII:7D0YB67S97

subject_name: Abatacept

object_name: rheumatoid arthritis


subject: UMLS:C0378942


subject: CHEBI:22652

subject_name: Ascorbic acid

object_name: adult acute respiratory distress syndrome


subject: CHEBI:601027

subject_name: Aliskiren

object_name: myocardial ischemia


subject: CHEBI:9927

subject_name: Valsartan


subject: CHEBI:9927

object_name: coronary atherosclerosis


subject: PUBCHEM.COMPOUND:78357831

subject_name: micafungin

object_name: leukopenia


subject: PUBCHEM.COMPOUND:78357831

object_name: neutropenia


subject: PUBCHEM.COMPOUND:78357831

object_name: Invasive fungal infection


subject: UMLS:C0879264


subject: UMLS:C0879264


subject: UMLS:C0879264


subject: UMLS:C0016004

subject_name: Beriplast P

object_name: tympanic membrane perforation


subject: CHEBI:7862

subject_name: Oxymetazoline

object_name: rosacea


subject: CHEBI:7862

object_name: Erythema


subject: CHEMBL.COMPOUND:CHEMBL2107910

subject_name: OLIVE OIL

object_name: Chronic kidney disease, Stage V


subject: CHEBI:42567

subject_name: Fisetin

object_name: common variable immunodeficiency


subject: CHEBI:42567

object_name: Acquired Hypogammaglobulinemia


subject: CHEBI:42567

object_name: Interstitial lung disease due to systemic disease


subject: GTOPDB:12989

subject_name: toripalimab

object_name: neoplastic meningitis


subject: UNII:8JXN261VVA


subject: UMLS:C4329337

subject_name: TAB 001


subject: CHEBI:95021

subject_name: pemetrexed


subject: CHEBI:63724


subject: UMLS:C1701110

subject_name: Zactima

object_name: renal carcinoma


subject: UMLS:C1701110

object_name: kidney cancer


subject: CHEBI:49960

subject_name: Vandetanib


subject: CHEBI:49960


subject: UMLS:C1384659


subject: UMLS:C1384659


subject: CHEBI:94518

subject_name: Tranexamic acid

object_name: Vaginal delivery (finding)


subject: CHEBI:94518

object_name: previous vaginal delivery (history)


subject: CHEBI:94518

object_name: postpartum hemorrhage


subject: CHEBI:94518

object_name: Post-partum hemorrhage


subject: UMLS:C3659483

object_name: adult glioblastoma


subject: CHEBI:190738

subject_name: Demethylated antipyrine

object_name: neuromuscular disease


subject: UNII:S798V6YJRP

subject_name: EDARAVONE


subject: CHEBI:31530

subject_name: Edaravone


subject: CHEBI:8802

subject_name: Remifentanil

object_name: pain agnosia


subject: CHEBI:8802

object_name: Pain insensitivity


subject: CHEBI:75045

subject_name: Dabrafenib

object_name: metastatic melanoma


subject: CHEBI:75998

subject_name: Trametinib


subject: UMLS:C4033631

subject_name: sacubitril / valsartan

object_name: Functional mitral regurgitation


subject: UMLS:C4033631

object_name: Heart failure with normal ejection fraction


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina

object_name: cardiovascular disorder


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: UMLS:C3265062


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UNII:721809WQCP

subject_name: Ruboxistaurin

object_name: diabetes mellitus


subject: CHEBI:61049

subject_name: Tacrolimus

object_name: Acute rejection of renal transplant


subject: CHEBI:61049

object_name: Chronic uremia


subject: CHEBI:94782

subject_name: Cediranib

object_name: ovarian cancer


subject: CHEBI:94782

object_name: ovarian neoplasm


subject: CHEBI:52993

subject_name: Lormetazepam

object_name: Alzheimer disease


subject: CHEBI:6539

subject_name: Lorazepam


subject: PUBCHEM.COMPOUND:44424639

subject_name: Vinorelbine

object_name: Childhood Breast Carcinoma


subject: PUBCHEM.COMPOUND:44424639

object_name: breast carcinoma


subject: PUBCHEM.COMPOUND:44424639

object_name: breast cancer


subject: CHEBI:93786


subject: CHEBI:93786


subject: CHEBI:93786


subject: UNII:4EQZ6YO2HI

subject_name: Denosumab

object_name: glucocorticoid-induced osteoporosis


subject: UMLS:C1530450

subject_name: AMG 162


subject: UMLS:C0359953

subject_name: bupivacaine / epinephrine

object_name: post thoracic surgery


subject: CHEBI:176724

subject_name: Etiracetam

object_name: Suspected cerebrovascular accident


subject: UNII:73HC18Y1LW

subject_name: LEVITIRACETAM


subject: CHEBI:6437

subject_name: Levetiracetam


subject: CHEBI:17026

subject_name: Progesterone

object_name: Postmenopausal


subject: UMLS:C2757070

subject_name: Progesterone [EPC]


subject: CHEBI:28748

subject_name: Doxorubicin

object_name: malignant soft tissue neoplasm


subject: CHEBI:28748

object_name: sarcoma


subject: CHEBI:28748

object_name: endometrial cancer


subject: CHEBI:28748

object_name: uterine corpus cancer


subject: CHEBI:28748

object_name: endometrial carcinoma


subject: CHEBI:8774

subject_name: Ramipril

object_name: cardiac allograft vasculopathy


subject: UNII:WC1U3R1YMI

subject_name: VEPDEGESTRANT


subject: UNII:WC1U3R1YMI


subject: UNII:WC1U3R1YMI


subject: UMLS:C5237163

subject_name: ER alpha PROTAC Protein Degrader ARV-471


subject: UMLS:C5237163


subject: UMLS:C5237163


subject: DRUGBANK:DB17595

object_name: leukocyte adhesion deficiency 1


subject: CHEBI:25681

subject_name: Omega-3 fatty acids

object_name: dry eye syndrome


subject: CHEBI:25681

object_name: Dry Eye, CTCAE


subject: CHEBI:25681

object_name: Dryness of eye


subject: CHEBI:8107

subject_name: Phenytoin

object_name: Depressed mood


subject: CHEBI:8107

object_name: Cancer patients and suicide and depression


subject: CHEBI:8107

object_name: Depressed - symptom


subject: CHEBI:8107

object_name: Depression, CTCAE


subject: CHEBI:184023

subject_name: Argininosuccinic acid

object_name: ulcer disease


subject: CHEBI:135207

subject_name: Clofedanol


subject: CHEBI:15365

subject_name: Aspirin


subject: PR:000004321

subject_name: arylsulfatase A


subject: CHEBI:50275

subject_name: Esomeprazole


subject: CHEBI:77260

subject_name: Omeprazole


subject: CHEBI:2955

subject_name: Azithromycin


subject: UMLS:C2003521

subject_name: insulin aspart, insulin aspart protamine drug combination 30:70

object_name: type 2 diabetes mellitus


subject: UMLS:C2003521

object_name: Diabetes


subject: UMLS:C2003521

object_name: diabetes mellitus


subject: UMLS:C0939905

subject_name: oats preparation

object_name: myocardial infarction


subject: UMLS:C0939905

object_name: Myocardial Infarction, CTCAE


subject: UMLS:C0939905

object_name: Myocardial Infarction by ECG Finding


subject: DRUGBANK:DB10546

subject_name: Oat


subject: DRUGBANK:DB10546


subject: DRUGBANK:DB10546


subject: PUBCHEM.COMPOUND:92043599

subject_name: epoetin alfa

object_name: leukopenia


subject: PUBCHEM.COMPOUND:92043599

object_name: neutropenia


subject: PUBCHEM.COMPOUND:92043599

object_name: hepatitis C


subject: PUBCHEM.COMPOUND:92043599

object_name: HIV infection


subject: CHEBI:81579

subject_name: Erythropoietin


subject: CHEBI:81579


subject: CHEBI:81579


subject: CHEBI:81579


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor

object_name: anemia


subject: PR:000005932

object_name: Anemia, CTCAE


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: CHEBI:8228

subject_name: Pioglitazone

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: CHEBI:8228

object_name: Leukemia - chronic myeloid leukemia (CML)


subject: UMLS:C1655276

subject_name: T-KI


subject: UMLS:C1655276


subject: UNII:DRP53ZDY6H

object_name: childhood neoplasm


subject: UNII:DRP53ZDY6H

object_name: neoplastic syndrome


subject: UNII:DRP53ZDY6H

object_name: cancer or benign tumor


subject: UNII:DRP53ZDY6H

object_name: neoplasm


subject: UNII:2Q1GS25JWN

subject_name: AVOTERMIN

object_name: Cicatrization


subject: UNII:2Q1GS25JWN

object_name: Pigmented Nevus


subject: UNII:2Q1GS25JWN

object_name: Nevus


subject: UNII:2Q1GS25JWN

object_name: epidermal nevus


subject: UMLS:C3179443

subject_name: avotermin


subject: UMLS:C3179443


subject: UMLS:C3179443


subject: UMLS:C3179443


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: malignant disease


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: UMLS:C0003442

subject_name: lymphocyte immune globulin, anti-thymocyte globulin


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: PR:000005932


subject: UNII:ZL1R02VT79

subject_name: Ranibizumab

object_name: Macular Edema


subject: UNII:ZL1R02VT79

object_name: Branch retinal vein occlusion


subject: UNII:ZL1R02VT79

object_name: central retinal vein occlusion


subject: UNII:A3ULP0F556

subject_name: Eculizumab

object_name: atypical hemolytic-uremic syndrome


subject: CHEBI:28887

subject_name: Ofatumumab

object_name: follicular lymphoma


subject: UMLS:C1541395


subject: CHEBI:45863

subject_name: Paclitaxel

object_name: peripheral vascular disease


subject: CHEBI:90001

subject_name: cystathionine ketimine

object_name: Atheroma


subject: CHEBI:90001

object_name: Inflammation


subject: CHEBI:90001

object_name: carotid artery disorder


subject: CHEBI:28082


subject: CHEBI:28082


subject: CHEBI:28082


subject: UMLS:C3813556

subject_name: Cancer/Testis Antigen


subject: UMLS:C3813556


subject: UMLS:C3813556


subject: PR:000050337

subject_name: mature calcitonin


subject: PR:000050337


subject: PR:000050337


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: chronic kidney disease


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UMLS:C3537249

subject_name: D Vitamin


subject: UNII:6897GXD6OE

object_name: Iron deficiency


subject: UNII:6897GXD6OE

object_name: iron deficiency anemia


subject: UMLS:C5943246

object_name: diabetic kidney disease


subject: CHEBI:8768

subject_name: Rabeprazole

object_name: Cough


subject: CHEBI:8768

object_name: Cough, CTCAE


subject: PUBCHEM.COMPOUND:135512673

subject_name: Rifampicin


subject: PUBCHEM.COMPOUND:135512673


subject: HMDB:HMDB0015179

subject_name: Rifampin


subject: HMDB:HMDB0015179


subject: CHEBI:44915

subject_name: Propofol

object_name: digestive system disorder


subject: PUBCHEM.COMPOUND:9824461

subject_name: remimazolam


subject: CHEBI:9316

subject_name: Sufentanil


subject: CHEBI:7627

subject_name: Norethisterone

object_name: uterine fibroid


subject: CHEBI:7627

object_name: uterine bleeding heavy


subject: PUBCHEM.COMPOUND:22064497

subject_name: Elagolix


subject: PUBCHEM.COMPOUND:22064497


subject: CHEBI:23965

subject_name: estradiol


subject: CHEBI:23965


subject: UNII:A3ULP0F556

subject_name: Eculizumab

object_name: myasthenia gravis


subject: UNII:A3ULP0F556

object_name: Myasthenia Gravis, CTCAE


subject: UNII:A3ULP0F556

object_name: Myasthenia Gravis, Generalized


subject: UNII:A3ULP0F556

object_name: Myasthenia gravis, juvenile form


subject: CHEBI:38290

subject_name: L-ascorbate

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:38290

object_name: obesity


subject: CHEBI:38290

object_name: Obesity, CTCAE


subject: CHEBI:176783

subject_name: vitamin C


subject: CHEBI:176783


subject: CHEBI:176783


subject: UMLS:C3714687

subject_name: Vitamin C Drug Class


subject: UMLS:C3714687


subject: UMLS:C3714687


subject: UMLS:C2349136

subject_name: Vitamin C Vitamins


subject: UMLS:C2349136


subject: UMLS:C2349136


subject: CHEBI:22652

subject_name: Ascorbic acid


subject: CHEBI:22652


subject: CHEBI:22652


subject: UMLS:C4522080

subject_name: Vitamin C [EPC]


subject: UMLS:C4522080


subject: UMLS:C4522080


subject: PUBCHEM.COMPOUND:3367

object_name: acute myeloid leukemia by FAB classification


subject: PUBCHEM.COMPOUND:3367

object_name: acute myeloid leukemia


subject: CHEBI:63599

subject_name: Fludarabine


subject: UNII:CD7WXM716P

object_name: Parkinson disease


subject: CHEBI:15367

subject_name: Tretinoin

object_name: plasma cell myeloma


subject: CHEBI:59902

subject_name: ENTECAVIR

object_name: liver cirrhosis


subject: CHEBI:59902

object_name: hepatitis B


subject: CHEBI:473990

subject_name: Entecavir


subject: CHEBI:473990


subject: PUBCHEM.COMPOUND:3249

subject_name: VITAMIN D2

object_name: vitamin D deficiency


subject: UMLS:C3714696

subject_name: Ergocalciferol Drug Product


subject: CHEBI:3732

subject_name: Clarithromycin

object_name: respiratory tract infectious disorder


subject: DRUGBANK:DB10500

subject_name: Almond

object_name: cardiovascular disorder


subject: CHEBI:9605

subject_name: Tirofiban

object_name: Ischemic stroke


subject: CHEBI:291342

subject_name: Desloratadine

object_name: urticaria


subject: CHEBI:291342

object_name: reported urticaria (physical finding)


subject: CHEBI:291342

object_name: Urticaria, CTCAE


subject: CHEBI:93862

object_name: Inflammation


subject: CHEBI:64213

subject_name: Cantharidin


subject: PUBCHEM.COMPOUND:44208979

subject_name: Acyline

object_name: hypogonadism


subject: PUBCHEM.COMPOUND:44208979

object_name: Gonadotropin deficiency


subject: UMLS:C0668202

subject_name: acyline


subject: UMLS:C0668202


subject: CHEBI:521033

subject_name: Dutasteride


subject: CHEBI:521033


subject: GTOPDB:1160

subject_name: hCG


subject: GTOPDB:1160


subject: CHEBI:81570

subject_name: Chorionic Gonadotropin (Human)


subject: CHEBI:81570


subject: UMLS:C0309130

subject_name: Follutein


subject: UMLS:C0309130


subject: UMLS:C1141639

subject_name: human chorionic gonadotropin


subject: UMLS:C1141639


subject: CHEBI:47519

subject_name: Ketoconazole


subject: UNII:B72HH48FLU

subject_name: Infliximab

object_name: inflammatory bowel disease 1


subject: CHEBI:5864

subject_name: Ifosfamide

object_name: ulcerative colitis


subject: CHEBI:5864


subject: CHEBI:95021

subject_name: pemetrexed

object_name: unspecified adult solid tumor, protocol specific


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: CHEBI:4672

subject_name: Docetaxel

object_name: Childhood Soft Tissue Sarcoma


subject: CHEBI:4672

object_name: Adult Soft Tissue Sarcoma


subject: CHEBI:4672

object_name: sarcoma


subject: CHEBI:4672

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: CHEBI:4672

object_name: soft tissue sarcoma


subject: UMLS:C4721782

subject_name: Pegargiminase


subject: UMLS:C4721782


subject: UMLS:C4721782


subject: UMLS:C4721782


subject: UMLS:C4721782


subject: CHEBI:35854

subject_name: Valaciclovir

object_name: genital herpes


subject: CHEBI:35854

object_name: Genital herpes male


subject: CHEBI:35854

object_name: genital herpes in women


subject: CHEBI:8228

subject_name: Pioglitazone

object_name: Androgen excess


subject: CHEBI:73024

subject_name: O-acetylcarnitine


subject: CHEBI:57589

subject_name: Acetylcarnitine


subject: GTOPDB:4934

subject_name: G-CSF

object_name: peripheral vascular disease


subject: GTOPDB:4934

object_name: peripheral arterial disease


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: UNII:PVI5M0M1GW


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: PR:000005932


subject: PR:000001786


subject: PR:000001786


subject: CHEBI:81570

subject_name: Chorionic Gonadotropin (Human)

object_name: spinal cord injury


subject: UMLS:C0309130

subject_name: Follutein


subject: UMLS:C1141639

subject_name: human chorionic gonadotropin


subject: GTOPDB:1160

subject_name: hCG


subject: CHEBI:5520

subject_name: gonadorelin


subject: PR:000008127


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: Erythematotelangiectatic Rosacea


subject: UMLS:C3529602

object_name: Post-Operative Pain


subject: CHEBI:50731

subject_name: morphine sulfate pentahydrate


subject: CHEBI:7852

subject_name: Oxycodone


subject: UNII:P76B05O5V6

subject_name: Relugolix

object_name: Locally advanced prostate cancer


subject: CHEBI:68534

subject_name: Enzalutamide


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: adult hepatocellular carcinoma


subject: UNII:2S9ZZM9Q9V

object_name: advanced adult primary liver cancer


subject: UNII:2S9ZZM9Q9V

object_name: Recurrent Adult Liver Carcinoma


subject: UNII:2S9ZZM9Q9V

object_name: Localized Non-Resectable Adult Liver Carcinoma


subject: CHEBI:114785

subject_name: Erlotinib


subject: CHEBI:114785


subject: CHEBI:114785


subject: CHEBI:114785


subject: MESH:C079198

subject_name: S 1 (combination)

object_name: pancreatic neoplasm


subject: MESH:C079198

object_name: exocrine pancreatic carcinoma


subject: MESH:C079198

object_name: malignant pancreatic neoplasm


subject: PUBCHEM.COMPOUND:73005958

subject_name: Carfilzomib

object_name: Plasma cell myeloma refractory


subject: PUBCHEM.COMPOUND:73005958

object_name: Extramedullary Disease in Plasma Cell Myeloma


subject: PUBCHEM.COMPOUND:73005958

object_name: Plasma cell myeloma recurrent


subject: UMLS:C1709429


subject: UMLS:C1709429


subject: UMLS:C1709429


subject: CHEBI:41879

subject_name: Dexamethasone


subject: CHEBI:41879


subject: UNII:LA88IH4O02

subject_name: Mezigdomide


subject: UNII:LA88IH4O02


subject: UNII:LA88IH4O02


subject: PUBCHEM.COMPOUND:3082777

object_name: prostate carcinoma


subject: PUBCHEM.COMPOUND:3082777

object_name: prostate cancer


subject: UMLS:C4083031

subject_name: ENA 713

object_name: Alzheimer disease


subject: CHEBI:134964

subject_name: Perflubutane

object_name: myocardial ischemia


subject: CHEBI:134964

object_name: coronary atherosclerosis


subject: MESH:C069727

subject_name: Sonazoid


subject: MESH:C069727


subject: PUBCHEM.COMPOUND:24892726

subject_name: Glucomannan

object_name: Functional constipation


subject: UMLS:C5565156

object_name: Moderate asthma


subject: UMLS:C5565156

object_name: asthma


subject: UMLS:C5425888

subject_name: Inhaled iloprost

object_name: lung cancer


subject: UMLS:C5425888

object_name: lung neoplasm


subject: UMLS:C5425888

object_name: lung carcinoma


subject: UMLS:C1527137

subject_name: Recombinant melatonin

object_name: fetal growth restriction


subject: UMLS:C1527137

object_name: Fetal Growth Retardation, CTCAE


subject: CHEBI:16796

subject_name: Melatonin


subject: CHEBI:16796


subject: UNII:5W7SK85BMU

subject_name: CABOTAMIG

object_name: digestive system cancer


subject: UNII:5W7SK85BMU

object_name: digestive system neuroendocrine tumor, grade 1/2


subject: UNII:5W7SK85BMU

object_name: Stomach cancer


subject: UNII:5W7SK85BMU

object_name: gastric cancer


subject: UNII:5W7SK85BMU

object_name: liver cancer


subject: UNII:5W7SK85BMU

object_name: liver neoplasm


subject: UNII:5W7SK85BMU

object_name: Adult Liver Carcinoma


subject: UNII:5W7SK85BMU

object_name: liver carcinoma